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Abstract
Batrachochytrium salamandrivorans (Bsal) is an emerging fungal pathogen of salamanders. Despite
limited surveillance, Bsal was detected in kept salamanders populations in Belgium, Germany, Spain,
the Netherlands and the United Kingdom, and in wild populations in some regions of Belgium,
Germany and the Netherlands. According to niche modelling, at least part of the distribution range of
every salamander species in Europe overlaps with the climate conditions predicted to be suitable for
Bsal. Passive surveillance is considered the most suitable approach for detection of Bsal emergence in
wild populations. Demonstration of Bsal absence is considered feasible only in closed populations of
kept susceptible species. In the wild, Bsal can spread by both active (e.g. salamanders, anurans) and
passive (e.g. birds, water) carriers; it is most likely maintained/spread in infected areas by contacts of
salamanders or by interactions with anurans, whereas human activities most likely cause Bsal entry
into new areas and populations. In kept amphibians, Bsal contamination via live silent carriers (wild
birds and anurans) is considered extremely unlikely. The risk-mitigation measures that were considered
the most feasible and effective: (i) for ensuring safer international or intra-EU trade of live
salamanders, are: ban or restrictions on salamander imports, hygiene procedures and good practice
manuals; (ii) for protecting kept salamanders from Bsal, are: identiﬁcation and treatment of positive
collections; (iii) for on-site protection of wild salamanders, are: preventing translocation of wild
amphibians and release/return to the wild of kept/temporarily housed wild salamanders, and setting
up contact points/emergency teams for passive surveillance. Combining several risk-mitigation
measures improve the overall effectiveness. It is recommended to: introduce a harmonised protocol
for Bsal detection throughout the EU; improve data acquisition on salamander abundance and
distribution; enhance passive surveillance activities; increase public and professionals’ awareness;
condition any movement of captive salamanders on Bsal known health status.
© 2018 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf
of European Food Safety Authority.
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Summary
Batrachochytrium salamandrivorans (Bsal; Phylum Chytridiomycota, Order Rhizophydiales) is an
emerging fungal pathogen of Caudata (salamanders and newts, from now on ‘salamanders’ in this
scientiﬁc opinion) that was identiﬁed in 2013. Many European salamander species seem to be
susceptible.
Upon request from the European Commission, in 2017, the European Food Safety Authority (EFSA)
has produced: (i) a scientiﬁc and technical assistance on Bsal as a disease with the potential to harm
kept and wild salamanders in the European Union (EU) with analysis of the various risk-mitigation
options associated with imports of salamanders (and their products and by-products) into the EU and
their trade within the EU; and (ii) the assessment of listing and categorisation of Bsal within the
framework of the Animal Health Law.
The European Commission has also requested from EFSA a scientiﬁc opinion dealing with various
aspects of the emerging pathogen, including environmental aspects, to understand the better possible
scenarios for the evolution of this new disease, the current epidemiological situation, the experience
gained so far from the implementation of the various control policies and possible alternative methods
to diminish the negative effects on wild salamander populations and to ensure safe trade of kept
animals and their products. Identiﬁcation of gaps and uncertainties is also very important for this
emerging disease.
Speciﬁcally, for this scientiﬁc opinion, EFSA was asked to assess: (a) as regards Bsal presence,
absence, surveillance and eradication: (i) the possible identiﬁcation of various areas (e.g. countries,
zones, territories) which may be considered infected with Bsal or free from it; and (ii) the suitability of
surveillance methods to ensure reliable and robust demonstration of the presence or absence of Bsal;
(b) as regards spread of Bsal in and from infected areas or via infected animals or fomites: (i) the risk
of survival, spread and establishment of Bsal within already infected areas and spread from infected
areas into other parts of the EU by natural movements of live salamanders taking into account
especially relevant geographical, hydrographical and meteorological conditions; (ii) the risk-mitigating
measures that could potentially be effective in ensuring safer international or intra-EU trade of live
salamanders (both captured in the wild and bred) and their products and by-products as regards the
transmission of Bsal including diagnosis and potential treatment(s); and (iii) the role of live silent
carriers of Bsal in spreading it as vectors and those of fomites (e.g. waste water, animal by-products.
feed) and their risk-mitigating measures; and c) as regards the protection of salamanders from Bsal:
(i) the potential and feasible risk-mitigating measures in kept salamanders and (ii) the risk-mitigating
measures for wild salamanders in their natural habitats.
The situation of Bsal is currently very dynamic, and since the European Commission mandate was
drafted several new cases and new knowledge has been reported. For instance, Bsal was found in wild
salamander populations in Germany and in kept populations in Spain. In addition, in May 2017, the
World Organisation for Animal Health (OIE) listed infection with Bsal in its Aquatic Animal Health Code,
and the EU, with Commission Implementing Decision 2018/320, laid down certain animal health
protection measures for import and intra-EU movements of salamanders in relation to Bsal that should
apply temporarily (at least until 31 December 2019) until more information is available to supplement
the current knowledge on Bsal.
This scientiﬁc opinion considers new information up to February 2018; methods included a
combination of literature review, analysis of available information on: (i) Bsal detection; (ii) salamander
abundance and distribution; (iii) how salamanders are transported and kept in captivity; and (iv)
amphibian products and by-products, and expert assessment of risk-mitigation measures.
It was concluded that Bsal surveillance is currently limited. Despite this situation, Bsal has been
detected in collections of captive salamanders in ﬁve EU Members States (MSs; Belgium, Germany,
Spain, the Netherlands and the United Kingdom), and in wild populations in some regions of Belgium,
Germany and the Netherlands. However, the absence of detection (in particular in the wild) does not
mean the absence of Bsal. According to niche modelling, at least part of the range of distribution of
every salamander species in the EU overlaps with the climate conditions predicted to be suitable for
Bsal. However, the assumed distribution range of salamander species is based on a large spatial scale.
Therefore, small-scale salamander habitat preferences may actually limit the total overlap between
Bsal and salamanders. Bsal-speciﬁc real-time polymerase chain reaction (PCR) (qPCR) has been shown
to have a high speciﬁcity and sensitivity, being a reliable and feasible diagnostic tool, and passive
surveillance is considered the most suitable approach for detection of Bsal emergence. Demonstration
of Bsal absence in wild populations of salamanders is currently considered not feasible, whereas it
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would be feasible to demonstrate the absence of Bsal in a ‘closed population’ of a susceptible
salamander species kept in captivity by sufﬁciently long quarantine and the absence of clinical
symptoms of Bsal conﬁrmed by visual observation. This should be complemented by testing all animals
at the end of a quarantine period.
In the wild, Bsal can possibly be spread by both active carriers (e.g. salamanders, anurans) and
passive carriers (e.g. wild birds, water). Bsal is most likely maintained and/or spread in infected areas
by intraspecies and interspecies contacts of salamanders but potentially also by interactions with
anurans. Bsal entry into new areas and populations is most likely to be caused by human activities
(mainly amphibian-related), but potentially also by wild birds, wild mammals and through connected
streams of water. For on-site protection of wild salamanders in their natural habitats, the risk-
mitigating measures that were considered the most feasible and effective ones are: preventing
release/return to the wild of kept or temporarily housed wild salamanders, preventing the translocation
of wild amphibians, and setting up contact points/emergency teams in support of passive surveillance.
Mitigation measures on hygiene procedures were considered feasible for anthropogenic sources of risk,
but less effective for natural mechanisms of spread (e.g. intraspecies or interspecies transmission,
potential carriers, such as wild birds). The effectiveness is likely to increase when combining several
mitigation measures as part of an integrated approach.
The risk-mitigation measures that were considered most feasible and effective in ensuring safer
international or intra-EU trade of live salamanders are: either a ban or restrictions on salamander
imports, hygiene procedures and good practice manuals. The feasibility and effectiveness of a ban or
restriction on salamander import and trade depend on the volumes of animals that are currently
transported; these measures might also boost illegal movements. The effectiveness of heat treatment
was also considered high. However, the heat tolerance of many salamander species is unknown.
Combining several risk-mitigation measures (in an integrated infection management strategy) improves
overall effectiveness. No information is available on import of salamander products and by-products,
however they are subjected to treatments (i.e. heat-processing or desiccation) that are considered
feasible and effective to ensure safe international and intra-EU trade.
In populations of kept amphibians, Bsal spread can potentially occur also via passive carriers such
as human movements and activities, waste water, equipment, substrate and fomites. These risks can
be mitigated by implementing hygiene procedures and good practices. Bsal contamination of traded
and/or kept salamanders via live silent carriers (wild birds and anurans) is considered extremely
unlikely, as, if good practices are implemented, salamanders are normally kept indoors and separated
from anurans. The risk-mitigation measures that were considered the most feasible and effective ones
for protection from Bsal of kept salamanders in captivity are: the identiﬁcation and treatment of
positive collections. However, also increasing stakeholders’ awareness (salamander breeders, keepers,
pet-shops and stores), good practice and hygiene protocols were considered feasible and their
effectiveness can be increased by combining the available measures into an integrated infection
management strategy.
Recommendations derived from these ﬁndings include: (i) introducing a harmonised protocol for
Bsal detection throughout the EU; (ii) improving data acquisition on abundance and distribution of
salamanders as well as enhancing passive surveillance activities for Bsal; (iii) increasing awareness
among professionals and the public; (iv) conditioning any movement of captive animals on known
health status (Bsal test negativity); and (v) distributing guidelines on hygiene procedures and best
practices to all relevant stakeholders and foreseeing that they become integral components of permits
for dealing with wild salamanders (site visitation, capture, handling and movement).
Bsal in salamanders
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1. Introduction
1.1. Background and Terms of Reference as provided by the European
Commission
Batrachochytrium salamandrivorans (Bsal) was identiﬁed by scientists as recently as in 2013. Over
the last couple of years Bsal has occurred at least in certain parts of Europe either in the wild
population of salamanders and newts (e.g. the Netherlands, Belgium in several locations) or in kept
population (e.g. Germany, UK) or possibly in both populations. There are no data from other EU
countries but similar cases either in wild or in kept salamanders cannot be excluded. In certain areas
(e.g. the Netherlands) this fungus is said to have devastated local ﬁre salamander populations. In
other places the fungus is apparently present in susceptible species, but without increased mortalities.
Many Asian salamander species seem to be immune or tolerant to this pathogen to various extents.
Many European species seem to be susceptible.
This situation and state of knowledge is patchy, fragmented and is expected to change as more
knowledge about this emerging pathogen and especially surveillance data become available,
continually and gradually. Overall, scientiﬁc data on Bsal are still scarce with signiﬁcant gaps. Currently
the disease is not listed under OIE standards or in the EU rules.
A few affected countries, or those that anticipate that Bsal could affect them, have adopted diverse
control policies or are considering various possible measures against the disease to cope with its
feared short-term and long-term consequences in wild animals and in kept salamanders and their
trade. One such example is an import ban of certain salamander species introduced by the USA, where
Bsal is either absent or not yet detected. Other measures are of a non-legislative nature, such as
raising awareness among stakeholders on risks, guidelines for improved biosecurity or survey
salamander populations, and any changes, with the emphasis on increased mortalities and/or
occurrence of Bsal. To date, these have been carried out under environmental policies.
Some individuals have recently called for inter alia, EU animal health policy and legislative measures
to be adopted, in particular an immediate ban on the import of many species of salamanders from Asia
into the EU. It has been shown by phylogenetic analysis that the fungus indeed originates in certain
parts of Asia. Therefore, it has been speculated by some that trade in Asian salamanders may have
played a role in its spread into and within the EU, although there is no proof that this pathogen
entered the EU via this route and, if so, when and under what circumstances. In general, details are
missing on its spread into or in the EU or between kept and wild animals.
The Commission therefore needs a quick but comprehensive compilation, scrutiny of available data
and assessment to determine if Bsal is a disease with the potential to harm kept and wild salamanders
in the Union and various risk factors associated with:
• imports of Asian salamanders into the EU and their trade within the EU;
• movements of European salamanders (both caught from the wild or kept ones) within the EU,
and imports and movements of animal by-products obtained from Asian and European
salamanders (both caught from the wild or kept ones).
Such assessment would be essential for the consideration of potential safeguard measures in
relation to imports from Asia or for movements from infected to non-infected EU areas.
In the past, EFSA has produced scientiﬁc opinions dealing with various aspects of emerging
pathogens, including those in which environmental aspects or wild animals play an increased role or
are affected (such as, for example, on small hive beetle). Therefore, a similar opinion is necessary to
understand better possible scenarios for the evolution of this new disease, the current epidemiological
situation, the experience gained so far from the implementation of the various control policies and
possible alternative methods to diminish negative effects on wild salamander populations and to
ensure safe trade of kept animals and their products. Identiﬁcation of gaps and uncertainties is also
very important for this emerging disease.
Furthermore, EFSA has already been made aware of the adoption and publication of the Regulation
on transmissible animal diseases (Animal Health Law, AHL). As Bsal is not included in the list of
diseases in Annex II to the AHL (or on the list of any other existing EU animal health legislation),
environmental players have asked the Commission to place Bsal onto that list. Therefore, a review of
this list will be necessary under a set of criteria provided for in the AHL before it comes into force,
taking into account the transitional periods envisaged for its application (ﬁve years starting from April
2016). Hence the Commission needs scientiﬁc advice for the assessment of the signiﬁcance of Bsal
Bsal in salamanders
www.efsa.europa.eu/efsajournal 7 EFSA Journal 2018;16(4):5259
within the framework of this already known listing and categorisation according to the AHL, in the
same manner as was requested previously for another two groups of diseases [Ref. SANTE G2/BL/lp
(2015) 4940871, SANTE G3/LPA/lp (2016) 3154863, respectively].
The criteria, provided for in Articles 7 and 8 and Annex IV of the AHL shall be used as a basis for
this analytical assessment. The risk manager needs a scientiﬁc advice to:
1) assess if Bsal causes disease for which control measures at the EU level are justiﬁed;
2) proceed with the proﬁling of the disease in view to its categorisation;
3) assign listed species to Bsal identiﬁed as eligible for EU intervention.
The Commission have identiﬁed the main issues for which concrete elements of science may
provide good basis for formulating policies and/or adapt current approach. These are as follows:
• provisions for safe trade (entry into the Union and trade within the Union) with Asian and
European salamanders and animal by-products obtained therefrom;
• identifying links between groups of salamanders in trade (i.e. in consignments being moved or
in shops, etc.) and kept ones (i.e. stationary, whether for hobby or else) and salamanders in
wild (i.e. in their natural habitat) and possible routes and risks of spreading Bsal between the
specimens belonging to the above three groups and locations;
• effects of the respective infection of salamanders with Bsal, including aspects stemming from
different susceptibility of various species to Bsal;
• measures to monitor occurrence of Bsal in those groups and mitigate mortality due to Bsal,
whether regulatory measures or non-regulatory ones.
1.1.1. Terms of Reference
I. Scientiﬁc and technical assistance in accordance with Article 31 of Regulation (EC)
No 178/2002
In view of the above, in accordance with Article 31 of Regulation (EC) No 178/2002, the
Commission asks EFSA to provide scientiﬁc and technical assistance concerning:
1) assessment of the potential of Bsal to affect the health of wild and kept salamanders in the
Union;
2) effectiveness and feasibility of a movement (including intra-EU trade and introduction from
non-EU countries) ban of traded salamanders, including both Asian and non-Asian species;
3) the validity, reliability and robustness of the available diagnostic methods for the detection
of Bsal;
4) possible alternative methods and feasible risk-mitigation measures to ensure the safe
international and EU trade of salamanders and their products.
II. Scientiﬁc opinion in accordance with Article 29 of Regulation (EC) No 178/2002
In accordance with Article 29 of Regulation (EC) No 178/2002, the Commission asks EFSA to
provide a scientiﬁc opinion on the following:
1) As regards susceptibility, morbidity and mortality, assess (EFSA, 2017):
a) the susceptibility and morbidity of various Asian and European salamanders to Bsal (also EFSA
AHAW Panel, 2017);
b) the nature of Bsal as facultative or not pathogen of European salamanders;
c) if there are species of salamanders carrying Bsal without clinical symptoms and/or clinical and
serological evidence and if so, which ones;
d) the mortality rates of native European salamander species due to Bsal (also EFSA AHAW
Panel, 2017);
e) the role of other factors (e.g. habitat degradation) in increased mortalities associated with
Bsal.
2) As regards presence, absence, surveillance and eradication, assess:
a) the risk of survival and establishment of Bsal in the environment in the EU under various
meteorological conditions (EFSA, 2017);
b) possible identiﬁcation of various areas (e.g. countries, zones, territories) that may be
considered infected with Bsal or free from it (this scientiﬁc opinion);
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c) the deﬁnition of requirements for reliable detection of Bsal in the wild in affected areas or
exclusion of its presence (EFSA, 2017; EFSA AHAW Panel, 2017);
d) the suitability of surveillance methods to ensure the reliable and robust demonstration of the
presence or absence of Bsal (this scientiﬁc opinion).
3) As regards spread of Bsal in and from infected areas or via infected animals or
fomites, assess:
a) the risk of survival, spread and establishment of Bsal within already infected areas and spread
from infected areas into other parts of the EU under various scenarios:
i) by natural movements of live salamanders taking into account especially relevant
geographical, hydrographical and meteorological conditions (this scientiﬁc opinion);
ii) by movements of traded live salamanders and their traded products, body parts, etc. from
infected areas, both under identiﬁed risk-mitigation measures or without (EFSA, 2017);
b) risk-mitigating factors that could potentially be effective in ensuring safe international or intra-
EU trade of live salamanders (both captured in the wild and bred) and their products and by-
products as regards the transmission of Bsal including diagnosis and potential treatment(s)
(this scientiﬁc opinion);
c) the role of live silent carriers of Bsal in spreading it as vectors and those of fomites (e.g.
waste water, animal by-products. feed) and their risk-mitigating measures (this scientiﬁc
opinion);
d) the possible routes of spread between kept salamanders, originating from international trade
and the autochthonous salamanders living in the wild, i.e. their natural habitat (EFSA, 2017;
EFSA AHAW Panel, 2017).
4) As regards on-site protection from Bsal, assess (this scientiﬁc opinion):
a) the potential and feasible risk-mitigating factors and methods in kept salamanders;
b) the risk-mitigating factors and methods for salamanders in their natural habitat.
5) Listing and categorisation of Bsal in the framework of the Animal Health Law (EFSA
AHAW Panel, 2017):
a) assess, following the criteria laid down in Article 7 of the AHL, its eligibility of being listed for
Union intervention as laid down in Article 5(3) of the AHL:
b) if found eligible to be listed for Union intervention, provide:
i) an assessment of its compliance with each of the criteria in Annex IV to the AHL for the
purpose of categorisation of diseases in accordance with Article 9 of the AHL;
ii) a list of animal species that should be considered candidates for listing in accordance with
Article 8 of the AHL.
1.2. Interpretation of the Terms of Reference
Batrachochytrium salamandrivorans (Bsal; Phylum Chytridiomycota, Order Rhizophydiales) was ﬁrst
described in 2013 (Martel et al., 2013) and is the pathogen of lethal chytridiomycosis in salamanders.
For taxonomic consistency, in this document the use of the term ‘salamanders’ is used as synonymous
of ‘Caudata’ and is inclusive of ‘newts’.
The situation of Bsal is currently very dynamic and since the mandate was drafted several new
cases and new knowledge occurred. For instance Bsal was found in wild salamander populations in
Germany and in kept populations in Spain. In addition, in May 2017, the World Organisation for Animal
Health (OIE) listed infection with Bsal in its Aquatic Animal Health Code (OIE, 2017), and the European
Union (EU), with Commission Implementing Decision 2018/3201, laid down certain animal health
protection measures for import and intra-EU movements of salamanders in relation to Bsal that should
apply temporarily (at least until 31 December 2019) until more information will become available to
supplement current knowledge on Bsal.
This scientiﬁc opinion considers new information up to February 2018.
1 Commission Implementing Decision (EU) 2018/320 of 28 February 2018 on certain animal health protection measures for intra-
Union trade in salamanders and the introduction into the Union of such animals in relation to the fungus
Batrachochytrium salamandrivorans. Ofﬁcial Journal L 62, 5.3.2018, pp. 18–33.
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The four Terms of Reference (ToRs) relevant to the scientiﬁc and technical assistance in accordance
with Article 31 of Regulation (EC) No 178/20022 (see point I above) have already been addressed by
EFSA with the scientiﬁc report published at the end of February 2017 (EFSA, 2017). The same report has
also addressed ToR 1, and some aspects of ToR 2 (points a and c) and of ToR 3 (points a–ii and d) of the
ToRs relevant to the scientiﬁc opinion in accordance with Article 29 of Regulation (EC) No 178/2002
(point II above).
A separate scientiﬁc opinion (EFSA AHAW Panel, 2017) has addressed ToR 5 and some aspects of
the other ToRs (i.e. ToR 1 points a and d; ToR 3 point d) of the ToRs relevant to the scientiﬁc opinion
in accordance with Article 29 of Regulation (EC) No 178/2002 (point II above).
Therefore, as speciﬁed in parentheses at the end of each ToR, this scientiﬁc opinion aims at
addressing the following ToRs relevant to the scientiﬁc opinion in accordance with Article 29 of
Regulation (EC) No 178/2002 (point II above): points b and d of ToR 2; points a–i, b and c of ToR 3;
and ToR 4.
For ToR 2b and d, the assessment will focus on the demonstration of the presence of Bsal. An
ecological model of Bsal presence leading to opportunity maps in the EU based on the currently
recorded ﬁndings on Bsal will be described; data from activities of Bsal early detection and active and
passive surveillance carried out in some Members States (MSs) will also be discussed. Considerations
on the difﬁculties of assessing and conﬁrming Bsal absence in the wild will also be provided.
Spread is the process of active or passive movement of the pathogen from one suitable area/
population to another area/population in which establishment can occur. For addressing ToR 3a–i, the
possible means of Bsal spread (carriers) in the salamanders’ natural habitats will be identiﬁed. It is
differentiated to ‘active carriers’, which are hosts acting like biological vectors for the spores, and
‘passive carriers’, which are similar to mechanical vectors to which the spores can be attached. Both
categories of carriers will then be categorised by their relevance for spread of Bsal in wild live
salamanders, in three scenarios: (i) within a subpopulation, (ii) from an infected area to an uninfected
area between subpopulations of the same meta-population, and (iii) from an infected area to an
uninfected area across geographical barriers (between meta-populations).
For consistency with the terminology used in other EFSA’s scientiﬁc outputs, for ToRs 3b, 4a and 4b
of this opinion, the assessment will refer to risk-mitigation ‘measures’ and not to ‘factors’.
For ToR 3b, the risk-mitigating measures that could potentially be effective in ensuring safer
international or intra-EU trade of live salamanders and reducing the risks of Bsal, will be described; a
qualitative assessment of the related feasibility and effectiveness will be performed also considering
the consequences. Considerations on possible salamander products and by-products as regards the
transmission of Bsal will be also provided. According to the wording of ToR 3c, the Bsal-silent carrier
concept refers to the Bsal-passive carriers. Information of these carriers of Bsal, their products and by-
products will be provided together with the relevant risk-mitigation measures.
‘On-site’ protection conventionally refers to wild animals in their natural habitats; in this opinion the
assessment of ToR 4 will refer to the protection of captive salamanders in places where they are kept
and the ‘on-site’ protection of wild salamanders in their natural habitats (ToR 4b). Measures that can
be put in place for their protection will be described and assessed for effectiveness and feasibility.
When no evidence on Bsal was available, but studies on the sister species
Batrachochytrium dendrobatidis (Bd) were available, reference to these studies on Bd has been
reported in this scientiﬁc opinion because the two fungi have been shown to be close enough to allow
making some generalisations on basic biological aspects for both species of the genus
Batrachochytrium (for more details, see EFSA, 2017).
2. Data and methodologies
2.1. Data
2.1.1. Data from the literature
Information from the papers selected as relevant from the Extensive Literature Search (ELS)
described in Section 2.2.1, and from additional literature identiﬁed by the experts was used for a
narrative description and assessment to address ToRs 2, 3 and 4; the results from a previous ELS
2 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in
matters of food safety. Ofﬁcial Journal L 31, 1.2.2002, pp. 1–24.
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carried out in 2016 for the EFSA Scientiﬁc Report on Bsal (EFSA, 2017) were also taken into
consideration for the assessment in this scientiﬁc opinion.
2.1.2. Salamander population data
The abundance of salamanders in the EU is still not comprehensively known.
Continuous population monitoring of the species in Annex II of the Council Directive 92/43/EEC on
the conservation of natural habitats and of wild fauna and ﬂora the Habitats Directive should be
performed by all the EU MSs.3
The salamander species of community4 interest (Annex II of the Council Directive 92/43/EEC) are:
Chioglossa lusitanica, Lyciasalamandra (synonym (syn.). Mertensiella) luschani, Salamandra aurorae
(Salamandra atra aurorae), Salamandrina terdigitata, Triturus carnifex, Triturus cristatus, Triturus
dobrogicus, Triturus karelinii, Lissotriton (syn. Triturus) montandoni, Lissotriton (syn. Triturus) vulgaris
ampelensis, Proteus anguinus, Speleomantes ambrosii, Speleomantes ﬂavus, Speleomantes genei,
Speleomantes imperialis, Speleomantes strinatii and Speleomantes supramontis. Data on the
monitoring results are publicly available online.5
Fragmented activities at EU level on collection of data on the size and distribution of salamander
population have been reported in the previous EFSA Scientiﬁc report (EFSA, 2017).
An inventory of all monitoring events in the different MSs requires extensive study, e.g. a survey with
all relevant stakeholders (governments, non-governmental organisations (NGOs), research and academic
institutions); this information is highly fragmented and not available in a central database. Monitoring
efforts are often project related in a deﬁned area or for some species. For example, Speybroeck and
Steenhoudt (2017) provided the example of an available database on Salamandra salamandra with
population relevant information.
On the basis of the experts’ knowledge, it was possible to identify some MSs that have put in place
systems for salamanders’ population monitoring and species distribution mapping.
Some countries (e.g. the Netherlands) have systematic, country-wide monitoring systems in place
(e.g. RAVON6). Some examples of taxon-speciﬁc monitoring programmes are: Salamandra salamandra
and Triturus cristatus monitoring in Flanders (Belgium) and the Netherlands, Salamandrina persipicillata
monitoring in Latium (Italy), amphibian monitoring in Sierra Norte de Sevilla (Spain), amphibian
monitoring in Bialowieza National park (Poland), and amphibian monitoring in Millevaches regional
natural park (France).
Another example is the situation in the Czech Republic, where it is organised by the National
Conservation Agency and includes four salamander species: Triturus cristatus, Triturus carnifex,
Triturus dobrogicus and Lissotriton montandoni. The data collected on the species are submitted to the
European Commission in 6-year cycles. Furthermore, long-term monitoring of selected species
(including all four before-mentioned Caudata) in a representative network of sites has been carried out
continuously since 2006, with the aim of detecting trends in populations. For Triturus cristatus, 30
permanently monitored sites are distributed in a regular fashion across the country. Each site is visited
at least three times in the season: two visits in time of reproduction and one in the time of larval
metamorphosis. Three options of quantiﬁcation of population size are used – capture success of larvae
and adults, visual counting of adults and live trapping success. Additional data on habitat quality and
changes are collected along with the salamander monitoring.
The International Union for Conservation of Nature (IUCN) Red List7 database also provides data on
the salamanders’ species distribution in the EU.
2.1.3. Data from Bsal surveillance systems
A Bsal surveillance programme is not currently harmonised across the MSs.
On the basis of the experts’ knowledge, it was possible to identify which MSs have put in place
passive or/and active Bsal surveillance systems.
3 http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:01992L0043-20130701
4 It is a formal term, for referring to (in full): ‘Annex II of the Council Directive 92/43/EEC: animal and plant species of
community interest whose conservation requires the designation of special areas of conservation’. http://eunis.eea.europa.eu/
references/2325/species
5 http://ec.europa.eu/environment/nature/knowledge/rep_habitats/index_en.htm
6 Reptile, Amphibian and Fish Conservation the Netherlands (RAVON), https://www.gbif.org/publisher/8629d002-c1cf-4c61-9895-
55ca7cd0e149
7 http://www.iucnredlist.org
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Data on active and passive surveillance have been collected for Salamandra salamandra and other
salamander species in some sites outside Prague in the Czech Republic, and for different species in
some regions of other countries, such as: Austria, Belgium, Croatia, France, Germany, Portugal, Spain,
Slovenia, Switzerland, the Netherlands and the UK. The surveillance has been non-systematic in the
MSs and was carried out on an ad hoc basis (for more details, see Section 2.2.2.2).
Results of the surveillance activities are reported in Section 3.1.1.3 and Appendix B.
The relevant data have been used to assess the surveillance approach to detect the presence of
Bsal and for feeding the discussion on demonstration of absence of Bsal (freedom from disease).
2.2. Methodologies
2.2.1. Extensive literature search
The previous ELS carried out in 2016 (EFSA, 2017) was updated by retrieving any peer-reviewed
and grey literature containing information on Bsal until October 2017. Full details of the search
protocol and strategy are reported in Appendix A.
The search yielded a total of 957 records. After de-duplication, the search resulted in 250 records.
A ﬁrst screening of all titles and abstracts was performed in parallel by two assessors to remove
additional duplicates (if any) and to identify the literature pertaining to Bsal or pertaining to related
aspects clearly relevant for Bsal, leading to 47 records (43 relevant papers plus 4 supplementary
materials). Full-text screening reduced the number of relevant papers to 26 (see Tables A.1 and A.2).
The identiﬁed papers were used to underpin the different ToRs.
The reference list of relevant review articles and key reports were checked for further relevant
articles and experts were invited to propose any additional relevant publications.
2.2.2. The approach to surveillance – Demonstration of Bsal presence, absence,
surveillance and eradication of Bsal (ToR 2)
2.2.2.1. Bsal niche modelling
Identiﬁcation of hosts or regions susceptible to colonisation by an emerging pathogen can be
achieved overlaying host distribution maps with regional mapping of Bsal suitable climate.
2.2.2.2. The climatic niche of Bsal
The climatic niche of Bsal has been modelled based on temperature and precipitation data of sites
of known occurrence of Bsal in its native Asian range and its invasive European distribution. The model
was recently described (Beukema et al., in preparation).8 The potential occurrence of Bsal was then
assessed for its overlap with the climatic niches of 56 putative Western Palearctic host species. Such
analyses may provide support for directed conservation actions, including mitigation prioritisation.
However, modelling the niche of a species (the range of climates where it is, or could be, present) is
complex, particularly, for invasive species. Typically, such correlative models for invasive species utilise
occurrence records in the species’ native area to estimate the species’ response to a range of
environmental factors that together deﬁne a species distribution (e.g. temperature or rainfall).
However, when moving into an invaded range, it cannot be guaranteed that the range of biotic and
abiotic conditions that were present in the native range also occur in the invaded range. For example,
a new combination of climatic factors might occur in the invaded range that have not been
encountered in the native range, resulting in model extrapolation beyond the data used to train the
model in the invaded region, which could affect model validity and accuracy. Similarly, ‘hidden’
components of a species niche that would be implicitly captured in models based on a native range
may be missing in the invaded range. This situation is particularly important for a pathogen, as the
characteristics of host–pathogen dynamics are often strongly mediated by hosts (as per Bd). As such,
care must be taken in evaluating the assumptions of building models from one host–pathogen system
(i.e. in native range) and projecting into another (i.e. invaded range).
8 The AHAW Panel had the opportunity to review the manuscript: Beukema W, Martel A, Nguyen TT, Goka K, Schmeller DS, Yuan
Z, Laking AE, Nguyen TQ, Lin CF, Sheldon J, Loyau A and Pasmans F. Environmental context and changes in niche structure
inﬂuence estimating Batrachochytrium salamandrivorans invasion risk in the Western Palearctic. In preparation.
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2.2.2.3. Bsal surveillance systems in Europe
In the Czech Republic, active surveillance of Bsal was carried out within Prague’s urban area and sites
in its vicinity. This activity started in 2015, in several sites considering the possibility of the pathogen to
spill over from kept salamanders to the wild. Samples of captive salamanders were available for Bsal
analyses from previous research projects (Havlıkova et al., 2015) and by collaboration with zoos and
private breeders. The sampling sites had a good accessibility to the live salamander populations, which
were tested by swabbing the skin; initially 126 samples from nine sites were collected in autumn 2015
and spring 2016 (Balaz et al., 2018). Sampling continued and altogether 12 sites were visited in search
of Salamandra salamandra. The ﬁrst visit on each site was performed to identify the exact microhabitats
of salamander occurrence and the possibility of sampling, taking around 3–4 person hours per site. The
second visit consisted of sampling, two people spending 3–6 h on site locating and sampling
salamanders. Pathogen diagnostic was performed by duplex real-time polymerase chain reaction (qPCR)
(Blooi et al., 2013). Although the surveys were originally planned to be repeated each year, in 2017, a
shortage of manpower and limited funding ceased he activities (Balaz et al., 2018).
Apart from the Directive 92/43/EEC9 on species’ monitoring (mentioned in Section 2.1.2), in the Czech
Republic a ﬁne-scale mapping scheme of all amphibians started in 2008 under the lead of the National
Conservation Agency (NCA CR) and since 2014 it covers the full extent of the country. The people
involved in the monitoring and mapping are informed about the need to collect and report dead and sick
animals to the Agency, which then contacts the researchers involved in chytridiomycosis research for
sample analyses.
To identify other countries where Bsal surveillance systems have been put in place, a questionnaire
was circulated by contacting research institutes, diagnostic laboratories and NGOs from Austria,
Croatia, France, Germany, Italy, Slovenia, Spain, Sweden, Switzerland, the Netherlands and the UK to
provide currently available data on Bsal investigations in wild amphibians in Europe.
Passive surveillance, using ‘disease emergency teams’, is in place in Belgium, France, Germany, Italy,
Spain, the Netherlands and the UK.10 All known Bsal outbreaks in Belgium, Germany and the Netherlands
were detected using passive surveillance. Funding for these teams (in the above-mentioned countries) is
provided by the European Commission until 2020. In Belgium, funding has been provided by the
government for yearly active surveillance of 10 sentinel populations of ﬁre salamanders in Flanders from
2015 until 2018 and for screening of 20 ﬁre salamander populations in Wallonia in 2016 and 2017.
In Austria, Belgium, Croatia, Czech Republic, France, Germany, Portugal, Slovenia, Spain,
Switzerland, the Netherlands and the UK, non-systematic active surveillance has been carried out on
an ad hoc basis.
For an overview of the surveillance systems currently in place in Europe and their funding, see
Table 1 below.
Table 1: Duration and funding of the active Bsal surveillance programmes place in some European
countries
Country Start End Funding
Austria 2016 2017 Mainly private, small part funded by state and research fund
Belgium 2015 2018 Government, research fund, European Commission
Croatia 2017 2018 Research fund
Czech Republic 2015 2016 University research funding
France 2017 2018 European Commission
Germany 2016 2018 Government, research fund, European Commission
Portugal 2015 2015 Research fund
Slovenia 2017 2017 Government, Slovenian research agency
Spain 2016 2017 Research fund, European Commission
Switzerland 2008 2013 Research fund
Netherlands 2013 2018 Government
United Kingdom 2014 2017 Government, European Commission, NGO, private foundation
9 Council Directive 92/43/EEC of 21 May 1992 on the conservation of natural habitats and of wild fauna and ﬂora. OJ L 206, 22
July 1992, pp. 7–50.
10 For more information: https//bsalinfoeurope.wixsite.com/eubsalmitigation2017
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2.2.3. Risk of survival, spread and establishment of Bsal within already infected
areas and spread from infected areas into other parts of the EU by natural
movements of wild live salamanders taking into account especially relevant
geographical, hydrographical and meteorological conditions (ToR 3a-i)
The Working Group (WG) experts were asked to produce from the available literature and their own
knowledge a list containing the possible means of Bsal spread into the salamanders’ natural habitat together
with their description and relevant geographical, hydrographical and meteorological considerations.
A consensus discussion addressed the means for the role in Bsal spread and entry. All means were
ranked by their relevance for spread of Bsal in wild live salamanders and put in three different categories
dependent on the following scenarios of spread: (i) within a subpopulation, (ii) from an infected area to
an uninfected area between subpopulations of the same meta-population, and (iii) from an infected area
to an uninfected area across geographical barriers (between meta-populations), using categories from ‘A’
to ‘C’. ‘A’ represents means that were categorised as most relevant for Bsal spread in a certain scenario,
whereas ‘B’ and ‘C’ were categorised as of lower importance. If necessary, subcategories were introduced
to express within category differences using small letters: a, b and c (see Table 2).
2.2.4. The approach to ToRs 3b, 4a, 4b
To address the following ToRs, the WG experts were asked to produce three lists from the available
literature and their own knowledge.
For ToR 3b on the transmission of Bsal, the main risk-mitigating measures that could be potentially
effective in ensuring safer international or intra-EU trade of live salamanders, their products and by-
products. The list of potential measures for Bsal management proposed by Grant et al. (2016) was
already assessed for relevance in EFSA (2017). For this scientiﬁc opinion, the experts were asked to
revise that list, and, on the basis of the new available knowledge, to add any additional mitigation
options that could be considered relevant and to assess them for feasibility and effectiveness.
For ToRs 4a and 4b, the risk-mitigating measures and methods for protection of salamanders where
they are kept in captivity and of populations of wild salamanders in their natural habitats (on-site),
respectively.
2.2.4.1. The assessment of feasibility
Feasibility of the identiﬁed measures was qualitatively assessed by the experts for ToRs 3b, 4a and 4b.
For ToR 3b, the feasibility of each of the risk-mitigating measures that were considered to be
potentially effective in ensuring safer international or intra-EU trade of live salamanders was assessed
on a continuous scale from ‘least feasible’ to ‘most feasible’, integrating aspects related to human
resources, technical efforts, treatment costs and environmental side-effects.
‘Least feasible’ means that the implementation of the measure demands extensive resources, e.g. it
requires lots of personnel (qualiﬁed personnel handling most of the individuals) and a large amount of
money (e.g. expensive reagents and facilities; complexity of monitoring the conduct), or if it is
dangerous to other species or the environment (e.g. causing toxicity – or resistance).
‘Most feasible’ means that the measure’s implementation demands few resources for personnel
(e.g. it does not require additional qualiﬁed personnel), amount of money (e.g. cheap reagents and
existing facilities/does not require reagents and facilities) and implies negligible danger to other species
or the environment.
For ToRs 4a and b, the feasibility of each of the risk-mitigating measures and methods that were
considered relevant for the protection of kept salamanders and for ‘on-site’ protection of populations
of wild salamanders in their natural habitats was assessed on a continuous scale from ‘least feasible’ to
‘most feasible’, integrating aspects related to human resources, stakeholder willingness to comply/
implement the measure, technical complexity, feasibility of monitoring the implementation, treatment
costs and long-term outlook, e.g. permanent efforts.
‘Least feasible’ is deﬁned as the implementation demanding extensive resources, e.g. when it
requires lots of personnel, or only few stakeholders will comply, when the implementation and conduct
of the procedures are complicated, if the resource needs are high, or requires new equipment or
facilities to be build/bought, and when a long-term outlook requires constantly high-level efforts.
‘Most feasible’ means that the measure’s implementation is straight forward, demanding few
resources (e.g. it requires few people per hour, no additionally qualiﬁed personnel is needed), most of
the stakeholders will comply, it requires inexpensive equipment and already existing facilities, when the
implementation and conduct procedures are simple, and a long-term application is easily sustainable.
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For all the three ToRs, after consensus appraisal of the outcomes of the individual judgements (see
details in Appendix C, Sections C.3.1, C.4.1 and C.5.1) and discussion of particular reasoning, the overall
outcome was represented by an interval covered by the central estimates across all experts. The quintiles
of value distribution of judgements were converted into a scale from 1 to 5 (see Tables 3, 4 and 5). The
broader is the reported interval, the greater is the uncertainty comprised in the judgements.
2.2.4.2. The assessment of effectiveness
Effectiveness of the identiﬁed measures was qualitatively assessed by the experts for ToRs 3b, 4a
and 4b.
For ToR 3b, the effectiveness to prevent translocation of Bsal through any means of each risk-
mitigating measure was assessed on a continuous scale from 0 – ‘no prevention’ to 1 – ‘blocking
measure’.
For ToRs 4a and 4b, the effectiveness of each measure to protect kept/wild salamanders against
Bsal infection was assessed on a continuous scale from 0 – ‘negligible’ to 1 – ‘fully protective’.
‘Negligible’ for kept salamanders means that the activity does not alter the exposure to Bsal
introduction to uninfected populations or the further perpetuation between salamanders within an
infected population; for wild salamanders, it means that the activity does not alter the exposure to Bsal
introduction of an uninfected site or the further perpetuation between salamanders on an infected site.
‘Fully protective’ means that the activity leads to refractory protection of uninfected salamanders in
a kept population against Bsal infection or that the activity leads to refractory protection of uninfected
wild salamanders on a site against Bsal infection (for on-site protection).
For all the three ToRs, after consensus appraisal of the outcomes of the individual judgements (see
Appendix C, Sections C.3.1, C.4.1 and C.5.1) and discussion of particular reasoning, the overall outcome
was represented by an interval covered by the central estimates across all experts. The quintiles of value
distribution of judgements were converted into a scale from 1 to 5 (see Tables 3, 4 and 5). The broader
is the reported interval, the greater is the uncertainty comprised in the judgements.
2.2.4.3. The assessment of uncertainty
In the experts’ judgement for ToRs 3b, 4a and 4b, a particular value was elicited and according to
EFSA’s Guidance (2014) the uncertainty of each judgement was quantiﬁed. Experts provided a
minimum and maximum to frame the elicitation and then the central value and the interquartile range
of the distribution were elicited (for details see Appendix C, Section C.2).
2.2.5. Identiﬁcation of amphibian products and by-products (ToR 3b and c)
Possible amphibian products and by-products have been identiﬁed on the basis of the experts’
knowledge, information gathered from the ELS from a ﬁrst search that was conducted using different
key words in Google such as: ‘amphibian products’, ‘amphibian derived products’, ‘animal by-products
list’, ‘products made from frogs’, ‘frog products’, ‘frog by-products’.
Based on the results more speciﬁc key words were used in web search engines (google, Web of
Science, European Commission website), such as: ‘Chinese giant salamander’, ‘salamander meat’,
‘frogs’ legs EU’, ‘frogs’ legs import EU’, ‘frogs’ legs frog species’, ‘EU trade of animal products’.
The potential of the identiﬁed amphibian products and by-products to pose a threat to EU
salamanders was then discussed by the experts (see Sections 3.2.3.1 and 3.2.4.6).
3. Assessment
3.1. Bsal presence, absence, surveillance and eradication (ToR 2)
3.1.1. Possible identiﬁcation of various areas (e.g. countries, zones, territories)
which may be considered infected with Bsal or free from it (ToR 2b)
3.1.1.1. Considerations on Caudata diversity and distribution in the EU
On the basis of the most recent scientiﬁc knowledge, the order Caudata is currently composed of
10 families divided into 68 genera and 710 species (from Amphibiaweb11). The taxonomy, distribution
and abundance, conservation status and trends of salamanders’ population have been described in
11 https://amphibiaweb.org University of California, Berkeley, CA, USA. Accessed 11 January 2018.
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details in a previous EFSA’s scientiﬁc report (EFSA, 2017). Compared with the previous EFSA
publication, a new family of salamander has been recognised in northern America: Dicamptodontidae,
which contains four species. This factor is only of taxonomical importance and it has no effect on the
situation in the EU.
EU MSs host a considerable salamander species diversity: 37 species are recorded to be present in
the wild (Temple and Cox, 2009; Sillero et al., 2014) and they pertain to three families:
Plethodontidae, Proteidae and Salamandridae (see also Table C.2 of EFSA, 2017).
Data on distribution of salamander species are available; however, abundance data are generally
not comprehensive.
The IUCN Red List contains data for 35 species present in the EU and Figure 1 shows their spatial
distribution.
3.1.1.2. Information on the habitat of the Caudata distributed within the EU
The European salamander species known to be susceptible to infection by Bsal (Appendix E of
EFSA, 2017) have variable habitat preferences and also differ in their dependency on the aquatic
environment.
The IUCN website12 was used for collecting the general information on salamander species
described below; additional references are reported when relevant.
The salamanders are in general nocturnal during the terrestrial phase and diurnal or with
continuous activity in the aquatic phase. Land salamanders can be active during daytime in rainy
weather. Migration of adult salamanders from land habitats to water occurs in most species before
reproduction over distances of several hundred metres (Kovar et al., 2009). The duration of the
aquatic phase of adults varies depending on the species. Juveniles usually leave the water shortly after
Figure 1: Map of the salamanders species distribution in the EU (data source: IUCN Red List; status:
11.11.2017) in which the number of species that occupy the same area/zone is represented
by different colours. As shown in the ﬁgure, up to seven different species of salamanders
may occupy the same area/zone
12 https://www.iucn.org
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metamorphosis. Although several species are often found at the same site, their habitat use
throughout the year may differ signiﬁcantly.
Salamandra salamandra is a broadly distributed species usually present in wet cool forests with
shaded brooks, small rivers or forest ponds, preferring humid microhabitats with dense leaf litter and
moss. Mating occurs on land and females only visit aquatic habitats to give birth to larvae, that
complete metamorphosis in water. Two subspecies are fully terrestrial giving birth to metamorphosed
young. Salamandra salamandra overwinters in underground refuges that protect the animals from
freezing, suitable sites can be used by multiple individuals repeatedly for several years. It can coexist
with several other salamander species on the same site (e.g. Ichthyosaura alpestris, Lissotriton sp.,
Triturus sp.).
The genus Speleomantes is present in Europe with eight species, each with a very localised
distribution. All species are fully terrestrial and live in humid rocky outcrops, caves, crevices and
forested areas in the vicinity of streams, usually on sites with dense growths of moss. All species
reproduce by a few directly developing terrestrial eggs, not visiting water bodies.
Triturus cristatus inhabits forests, pastures, meadows, parks and gardens. It reproduces in ponds or
semi-ﬂowing waters. Adults spend around 5 months in the aquatic habitat, but most individuals
overwinter on land.
Lissotriton italicus is often associated with woodland and agricultural habitats. It breeds in
temporary ponds, ditches, slow-moving streams and lakes. It is also found in modiﬁed habitats, such
as wells and water tanks. Adults spend several months in aquatic environment, but aestivate (summer
dormancy) and hibernate on land.
Lissotriton vulgaris is the species with the broadest distribution among European salamanders and
it is an adaptable species occurring in woodland habitats, meadows, parks, gardens, various damp
habitats as well as in rural and urban areas. The species breeds in still and slow-moving shallow
waters and irrigation ditches. Mating and reproduction occur in water, adults remaining in the aquatic
phase for several months. This species hibernates on land. Often a single hibernation site is used by a
large number of adults and juveniles (Barus and Oliva, 1992).
Ichthyosaura alpestris is a predominantly aquatic species generally found close to water, inhabiting
forests, subalpine meadows and pastureland. The species is not very selective in choosing breeding
sites, provided they are not stocked with predatory ﬁsh. Mating and larval development takes place in
variety of stagnant waters and sometimes in slow-moving streams. Hibernation occurs on land, but
larvae sometimes overwinter in water before metamorphosis in the following season (Barus and Oliva,
1992). Fully aquatic neotenic (adults retain larval gills) populations occur in some areas (IUCN, online).
Pleurodeles waltl is a highly aquatic species of Mediterranean-type habitats including scrub, open
woodland and cultivated land. It is generally found in water bodies with dense aquatic vegetation. It is
adapted to survive on land using shelter when the aquatic habitat dries up. Hibernation takes place in
the aquatic habitat.
Euproctus platycephalus inhabits mountainous areas with permanent and temporary stagnant and
running waters; in rivers, it prefers calm areas. Its terrestrial habitats are generally restricted to
riverine scrub or woodland, and the species may also be found in cave systems. Its breeding sites are
permanent pools, water holes, small lakes and streams. The eggs are deposited between stones or are
buried in sand; the larvae develop in the streams (Grifﬁths, 1996). The species is quite adaptable and
can be found in artiﬁcial pools. Hibernation takes place in the aquatic habitat.
Salamandrina perspicillata is mainly found in forests with dense undergrowth in hilly and
mountainous areas. Only females of this species are aquatic during the short oviposition phase for
which well oxygenated waters, slow running streams or small ponds are used (IUCN, online).
3.1.1.3. Identiﬁcation of EU zones that may be considered infected with Bsal
Wild salamanders
In the EU, a large proportion of genera of the family Salamandridae and the genera Speleomantes
of the family Plethodontidae has been shown to be wildlife species naturally and/or experimentally
susceptible to Bsal. In addition, Bsal has been shown to cause very high mortality in some species
(e.g. Salamandra salamandra) (for reference, see EFSA AHAW Panel (2017) and EFSA (2017)). In the
species Salamandra salamandra, introduction of Bsal leads to a fast population collapse (Martel et al.,
2013; Spitzen-van der Sluijs et al., 2013; Stegen et al., 2017).
To date, Bsal obvious mortality has been detected only for certain salamander species (e.g.
Salamandra salamandra; for more details, see EFSA (2017)). However, infection of wild anurans with
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Bd has been associated with both mass mortality events but also less obvious, slow, and in some
cases cryptic, population declines even at very low prevalence of infection, after the disease has
become endemic (e.g. Murray et al., 2009; Pilliod et al., 2010; Valenzuela-Sanchez et al., 2017).
In Belgium, no Bsal was detected via active surveillance. All Bsal-positive sites (Eupen, Dinant,
Liege and Robertville) were detected via passive surveillance (in Salamandra salamandra). Bsal
infection loads were monitored for 2 years after the detection of a Bsal outbreak in Robertville (Stegen
et al., 2017). No more Salamandra salamandra (juveniles or adults) have been found at the outbreak
sites in Eupen in 2017 (outbreak detected in 2013) and Robertville in 2017 (outbreak detected in
2014). In the outbreak site in Bunderbos, in the Netherlands (ﬁrst Bsal-positive animals detected in
2010 via retrospective testing after discovery of the pathogen), Salamandra salamandra tested
negative for Bsal in 2015 (2 animals) and in 2017 (35 animals).
Screenings in the UK in wild populations were carried out in 2014–2017 and no Bsal was detected
(unpublished data, Andrew A. Cunningham, Institute of Zoology, Zoological Society of London,
personal communication, 2018). Also, the results of the surveillance in the Czech Republic were all
negative (Balaz et al., 2018).
No screenings have been performed in Italy and Sweden.
The results of the surveillance activities carried out in some European countries (see also
Section 2.2.2.2) are summarised in Figure 2a as a result of what is currently known about Bsal
presence in Europe. Some of the data are still unpublished (see also Appendix B). No information on
Bsal screenings or surveillance activities is available from the remaining MSs.
Kept salamanders
In addition, the disease has been detected in collections of captive salamanders in Belgium,
Germany, Spain, the Netherlands and the UK (see Figure 2b; Sabino-Pinto et al., 2015; Fitzpatrick
et al., 2016, In Preparation). The salamander species that have died due to conﬁrmed and natural Bsal
infection in captivity are: Ichthyosaura alpestris, Salamandra algira, Salamandra salamandra (including
the subspecies alfredschmidti, almanzoris, bernardezi, fastuosa, gallaica, gigliolii, salamandra,
terrestris, werneri), Salamandra atra, Salamandra corsica, Salamandra infraimmaculata, Triturus
macedonicus, Triturus marmoratus, Notophthalmus viridescens, Taricha granulosa and Lissotriton
boscai (Sabino-Pinto et al., 2015; An Martel and Frank Pasmans, University of Ghent, personal
communication, 2018).
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The only existing detailed analysis of disease and population dynamics in an affected wild
subpopulation was recorded in Robertville (BE) and is described by the disease monitoring in Figure 3
showing frequency of infected and uninfected salamander detections through time since the ﬁrst
recording of the outbreak.
Figure 2: Maps with current knowledge of Bsal in Europe based on the screening and surveillance
activities. (a): Actual distribution of where Bsal has been conﬁrmed to be present (red
colour) and where the surveillance systems have not conﬁrmed its presence (green colour)
in wild populations of salamanders: if in the given period of time at least one individual
(without considering the species) has been Bsal-positive tested, the region/area has been
considered as positive (red-coloured). In grey the areas/regions where no information is
available. Data and results of the surveillance activities carried out in Austria, Belgium,
Croatia, Czech Republic, France, Germany, Portugal, Spain, Slovenia, Sweden and the
Netherlands are detailed in Appendix B. (b): EU MSs where collections of salamanders in
captivity have been Bsal tested positive
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Predictions generated from climatic niche modelling based on native Bsal records suggest the
possibility of an extensive distribution across Europe, in addition to parts of the North African
Mediterranean shore and Anatolia. The distribution range of every salamander species in Europe is
likely to overlap with climate conditions that are suitable for Bsal. The current Bsal distribution appears
to be only a small fraction of the potential distribution as predicted by niche modelling. This suggests
that invasive Bsal could continue to spread and expand its distribution in Europe and pose an
increasing risk to salamander diversity across the Western Palearctic (Beukema et al., submitted).
Climate conditions suitable for Bsal modelled earlier in Feldmeier et al. (2016) also support the
possibility of further Bsal spread in Europe.
However, the assumed distribution range of salamander species is based on a gross spatial scale.
Therefore, small-scale salamander habitat preferences may actually limit the total overlap between Bsal
and salamanders. The assessment could be reﬁned using an ecological niche model of salamanders
including small-scale habitat categories, such as vegetation characteristics, wetland distribution,
ecological corridors (Guevara et al., 2018). However, these data are not currently available.
3.1.2. Suitability of surveillance methods to ensure reliable and robust
demonstration of presence or absence of Bsal (ToR 2d)
3.1.2.1. Protocol for Bsal diagnosis
In addition to a case deﬁnition for infection with Bsal (White et al., 2016), several diagnostic methods
for Bsal detection have been described, including histology/histopathology, immunohistochemistry, PCR,
qPCR and lateral-ﬂow technology (Blooi et al., 2013; Martel et al., 2013; Dillon et al., 2017; Thomas
et al., 2018). PCR and qPCR are currently the only diagnostic methods that can distinguish between Bsal
and its sister species Bd.
The Bsal qPCR developed by Blooi et al. (2013) has the advantage of simultaneously identifying
and quantifying Bsal in amphibian samples. Conservative values of test sensitivity and speciﬁcity under
ﬁeld conditions were proposed previously (EFSA, 2017; EFSA AHAW Panel, 2017); Bsal-speciﬁc qPCR
Figure 3: Frequency distribution of Bsal-infected and Bsal-uninfected individuals of
Salamandra salamandra found per visit in Robertville (BE) beginning with the detection of
the outbreak in 2014. Overtime the decline of the probability to detect even any
salamander was modelled with the Poisson distribution. As can be observed, the size of the
population dramatically decreased within a few months. The two clusters of positive
ﬁndings relate to the main activity periods of the hosts. (Reprinted by permission from:
Springer Nature, Nature, Drivers of salamander extirpation mediated by Batrachochytrium
salamandrivorans, Stegen et al., 2017 ©)
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assay detects 0.1 Bsal genomic equivalents (GE) and has shown an average experimental sensitivity
ranging from 96.2% to 100% and an average speciﬁcity of 100% (Thomas et al., 2018).13 This qPCR
can be performed on non-invasively collected skin swabs and the test is able to detect the fungus
before the animal shows clinical signs of disease (Martel et al., 2014). Non-invasive sampling protocols
that have been developed for Bd diagnosis (Hyatt et al., 2007; Skerratt et al., 2008) are currently used
to collect samples from live wild and captive amphibians for testing the presence of Bsal.
The test sensitivity of qPCR should be used to estimate the sample size needed for any surveillance
purposes.
The EC has launched a call for tender (ENV.B.3/SER/2016/0028) and it is setting up an EU network
of diagnostic centres. Laboratories in Austria, Belgium, the Czech Republic, Croatia, France, Germany,
Italy, Slovenia, Spain, Sweden and the UK have participated and successfully completed the Bsal ring
test. The list of these laboratories is available online14 and it will be updated as new laboratories
participate in the testing.
For any salamander species, diagnosis with Bsal-speciﬁc real-time PCR needs to be performed over
the last week of any quarantine and at the moment of handling a free-living or kept individual if
surveillance takes place.
3.1.2.2. Bsal surveillance
Surveillance of wildlife diseases in an area, zone or region (i.e. population unit) has different goals
consequent to the acute knowledge about the disease in this population unit. With Bsal, the goal is to
detect at an early state its introduction into or its spread within the unit. Subsequently, the goal is to
monitor the salamander population known to be Bsal affected until eventually no more Bsal-infected
animals are sampled, and thereby document absence of the pathogen in the population unit. This
situation-oriented surveillance concept was shown to be purposeful for other wildlife disease
surveillance planning, in particular for efﬁcacy and resource requirements (Thulke et al., 2009). The
following paragraphs consider the proposed surveillance activities (passive vs active) in the context of
Bsal and identify beneﬁcial protocols, drawbacks and purposeful interpretation following diagnostic
results derived for a population unit. Conceptually, the epidemiological absence of the pathogen from a
population unit is considered different from a ‘freedom from disease’ approach, ascertaining prevalence
unlikely to be above a certain detection threshold.
Passive Bsal surveillance
Passive surveillance consists of opportunistic detection of dead individuals and testing of these for
Bsal infection. It implies that all salamanders that are found dead need to be Bsal tested.
Entry of Bsal into a habitat area or subpopulation of European host species is associated with
substantial mass mortality in the animals. On the basis of the surveillance activities currently in place in
some MSs (see Section 2.2.2), and considering the lack of information on the geographical structure of
salamanders’ population prerequisite to a valid sampling scheme in live salamanders, passive
surveillance was considered as the surveillance system most ﬁt for the timely detection of Bsal
emergence in wild host populations.
To enhance the procedure in context of Bsal independent visits of host populations, a protocol
should be implemented that rises awareness of dead animals and gives details for the subsequent
delivery of Bsal exclusion diagnosis, including the methodology for packing the samples i.e. dead
animals.
If people ﬁnd a dead animal, they should immediately alert the contact point/disease emergency
team for collecting the samples. The contact point is in charge of correctly collecting the samples and
bringing to a laboratory for the testing and georeferencing the ﬁndings.
Practical information for collecting the samples is reported for Bd (Murray et al., 2011a).
13 The study investigated the test sensitivity of different Bsal testing tools in four different laboratories. The ﬁrst three
laboratories used Bsal-speciﬁc real-time PCR (qPCR) for detecting Bsal, whereas the fourth used droplet digital PCR (ddPCR).
For qPCR, the average test sensitivity was: laboratories 1 and 2 = 100% (conﬁdence level (CL): 95% and conﬁdence interval
(CI):86.6–100%); Laboratory 3 = 96.2% (CL: 92.6%; CI: 80.4–99.9%), whereas the laboratory 4 showed a lower average
test sensitivity = 92.3% with CL of 95% and CI of 75–99%. This difference was considered to be due to the different
technique that was used in the fourth laboratory.
14 https://docs.wixstatic.com/ugd/1ecffe_b77e2c99423844c191f61e6ecb478fb9.pdf
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Active Bsal surveillance
Active surveillance can be deﬁned as a systematic check of all local populations (subpopulations) in
the wild for sentinel purposes and testing for Bsal. Skin swab samples have to be collected from
randomly selected live wild salamanders. Detection of Bsal emergence would be as early as the
temporal schedule of the visits prescribes. To date, mainly non-systematic active surveillance activities
exist covering the host population of Bsal in the EU MSs; the main limitations for a Bsal surveillance
strategy regard the lack of data on host population, size and distribution. However, possible reasons
might be related also to the fact that the activity would require substantial resources to become
sufﬁciently sensitive, issues with physical accessibility of subpopulations and implications for
unintentional translocation of the fungus due to necessary additional visits. In summary, a systematic
active surveillance strategy cannot be considered the ﬁrst choice for Bsal detection due to feasibility
and practicality issues.
If a Bsal outbreak has already been detected, however, active surveillance and monitoring of Bsal
dynamics may be advised for, e.g. appropriate conservation decisions.
If active surveillance is planned, overarching protocols are suitable (Wobeser, 2007) and the
following steps apply to Bsal:
• Sample deﬁnition
• Where to sample?
• When to sample (seasonality)?
• How many samples should be taken (sampling size)?
• Which species should be sampled?
• Which diagnostic test should be used?
Sample deﬁnition
The sample should consist of skin swabbing from live wild salamander populations. Only people
with the speciﬁc permit can carry out this activity.
Where to sample?
Terrestrial salamander species (e.g. Salamandra salamandra), and newt species during their
terrestrial life stage, can be sampled, either by active search or by using pitfalls. For aquatic life
stages, dipnets or aquatic traps (ﬁkes) can be used to catch newts in suitable reproduction habitats
(depending on species: ponds, streams, etc.).
When to sample (seasonality)?
The detection of Bsal is much related to the retrieval of the hosts; therefore, for practical reasons,
the surveillance activities should take the natural activity of salamanders into account. For terrestrial
Caudata, disease surveillance is useful only during activity periods, which are highly dependent on local
climatic conditions and the Caudata species involved (e.g. for many terrestrial salamanders in
Mediterranean systems: activity mainly dictated by humidity, in temperate and high elevation regions
by humidity and temperature). For aquatic Caudata, sampling should be conﬁned to the aquatic
activity season, which varies according to species, habitat and local climatic conditions (e.g. in high
elevation species: activity peak in the summer, Mediterranean climate: often in the winter; temperate
climate: often in the spring).
How many samples should be taken (sampling size)?
In Table 3 of EFSA AHAW Panel (2017), the calculations of the sample size15 were provided for the
conservative assumptions of 80% test sensitivity under ﬁeld conditions based on the laboratory
estimates of diagnostic sensitivity of about 96% (Thomas et al., 2018).
The calculations should consider all the susceptible, tolerant and reservoir species present when the
target population size is determined. Considering that reservoir species are less reliable for Bsal
detection, the sampling should put preferences on susceptible species. In any case all salamanders
that are found dead should be tested.
15 For providing the 95% probability of detecting at least one positive animal according to different population sizes and
minimum expected prevalence of 1%, 3% and 10%.
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Which species should be sampled?
On the basis of the current available knowledge, individuals of all the susceptible, tolerant and
reservoir species should be included. However, in tolerant and reservoir species, infection may have
low intensity (DiRenzo et al., 2017). If there is a particular susceptible species present, sampling effort
should be focused on this species.
An overview of the salamander species that are considered Bsal susceptible, tolerant and reservoir
is provided by EFSA AHAW Panel (2017). The same document reports a list of salamander species that
are suggested to be listed for Bsal according to the criteria of Art. 8(3) of the Animal Health Law.16
Among these species, those reported present in the wild in the EU should be included in an EU
surveillance system.
However, the experts highlighted that the species susceptibility cannot be the only element on
which to base a surveillance system. The other fundamental items to be taken into consideration for
recommending which salamander species would be the most relevant for inclusion in surveillance
systems are: inclusion in the Annexes of the Habitats Directive, potential points of entry, range and
population sizes, and species distribution (Nusser et al., 2008).
Small-range species with small population sizes are predicted to be the most vulnerable to
extinction processes (Sodhi et al., 2008) and together with species already classiﬁed as threatened
(e.g. by IUCN or at national level) should be considered of high priority. Widespread and abundant
species can be used as sentinel species (e.g. Salamandra salamandra).
Recommendations should be made on a risk analysis per species. However, currently, there is not
enough knowledge on the items mentioned above and a risk analysis leading to a prioritised list of
European Caudata species is pending. For this reason, the European Commission has launched a call
for tender ‘Mitigating a new infectious disease in salamanders to counteract the loss of European
biodiversity’ to get information/data on possible emergency action plans, including species
prioritisation. The project involves seven partners, it started in March 2017 and is planned to be
ﬁnalised by March 2020.
Which diagnostic test should be used?
Bsal-speciﬁc qPCR (see Section 3.1.2.1).
Demonstration of Bsal absence
Establishing the absence of disease can, in theory, help focus risk-mitigation actions by restricting
them to those that may prevent invasion/establishment in areas with the known or suspected absence
of the disease. For example, such demonstrations were a key reason underpinning the decision to
impose a complete trade ban on salamanders in the USA and some authors have used absence of
detection to suggest appropriate management steps at a regional scale as well (e.g. Wang et al., 2017).
To put in place a surveillance system to demonstrate the absence of a pathogen, the host
population should be known and access to all host populations needs to be regularly advised. For Bsal,
the knowledge of the salamander population is extremely poor. Available data are insufﬁcient to
monitor the presence of Bsal or demonstrate its absence. Moreover, assumptions on population size or
on background prevalence, both necessary as an input to statistical or sample-based absence
demonstration, cannot be formulated with purposeful certainty.
Sampling activities to demonstrate the absence from Bsal in the wild suffer practicality issues.
Finding enough animals within a given habitat (e.g. 1 km2) to satisfy sample size requirements, very
likely turns impractical; e.g. the sample size needed for providing the 95% probability of detecting a
design prevalence of 1% would be 373 animals, assuming an inﬁnite population size, a diagnostic test
sensitivity of 80% and diagnostic test speciﬁcity of 100% (see Table 3 in EFSA AHAW Panel, 2017).
Moreover, the target population unit that justiﬁes the proposition of a proper design Bsal prevalence
value is not yet deﬁned. Even if no positive samples are found in a speciﬁc area/zone, it cannot be
stated that Bsal is absent in that speciﬁc area/zone; it just means that no positives have been sampled
in the tested population. In conclusion, the epidemiological demonstration of Bsal absence in wild
populations of salamanders may be considered unfeasible.
A more purposeful approach assumes the absence as long as no Bsal-infected population has been
detected by enhanced passive surveillance activities. Bsal infection is leading to substantial mass
morbidity and mortality in infected populations and therefore falls under such surveillance concepts
16 Regulation (EU) 2016/429 of the European Parliament and of the Council of 9 March 2016 on transmissible animal diseases
and amending and repealing certain acts in the area of animal health (‘Animal Health Law’). OJ L 84, 31.3.2016, pp. 1–208.
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(Thulke et al., 2009). For such pathogens/diseases, enhanced surveillance focusing on individuals
found dead is the most effective indication of their presence. Passive surveillance is suggested for early
detection; therefore, if enhanced passive surveillance remains negative, the assumption of Bsal still
being absent is justiﬁed.
Alternatives in kept salamanders
In a ‘closed population’ of susceptible salamander species kept in captivity, the owners have access
to each individual. Therefore, a whole population testing would in principle be feasible. In that sense,
it is considered feasible to demonstrate absence of Bsal by sufﬁciently long quarantine and absence of
clinical symptoms of Bsal conﬁrmed by visual observation. This should be complemented by testing all
animals at the end of a quarantine period (e.g. 6 weeks for Salamandra salamandra, see
Section 3.2.3.3). In this scenario, such epidemiological freedom from Bsal can be maintained when
exchanges are limited to conﬁrm Bsal-negative animals from other ‘closed populations’. Premovement
health certiﬁcation should accompany the translocated animals (see Section 3.2.3.3) and the absence
of clinical symptoms of Bsal should be conﬁrmed by visual observation. The above-mentioned scenario
is conditional on appropriate implementation of hygiene procedures and good practices (see
Section 3.3.2).
In the scenario of ‘close populations’, the use of a sentinel, a susceptible individual to be cohoused
during the quarantine, has been considered as an alternative to Bsal testing of all the salamanders at
the end of the quarantine. Possible sentinel species are Salamandra salamandra and other hyper
susceptible species (see Martel et al., 2014). However, this possibility should be further explored as
currently there are not enough data to support the use of sentinel animals in the detection of Bsal
presence/demonstration of Bsal absence. In addition, the possible inter-species toxicity should be
carefully considered before co-housing different salamander species.
3.2. Spread of Bsal in and from infected areas or via infected animals or
fomites (ToR 3)
3.2.1. Protocols for Bsal disinfection and treatment
3.2.1.1. Bsal disinfection
An overview of effective disinfection protocols is provided in Van Rooij et al. (2017).
The procedure for disinfecting equipment, fomites and other items that might have been
contaminated by Bsal, after their cleaning, consists of: 1% Virkon S®, 4% sodium hypochlorite and 70%
ethanol for disinfecting equipment in the ﬁeld, lab or captive setting, with a minimal contact time of 5 min
for 1% Virkon S® and 1 min for the latter disinfectants (Van Rooij et al., 2017). To treat Bsal-
contaminated materials, the use of high temperatures has also been proposed (EFSA AHAW Panel, 2017).
3.2.1.2. Treatments of Bsal-infected animals
Depending on the species, the infected salamander can be treated by an elevated environmental
temperature (heat treatment) or with antimicrobials. Post-treatment assessment of Bsal absence is
necessary and the treatment may need repeating until total clearance of Bsal infection.
Heat treatment
Ten days exposure to 25°C clears salamanders from Bsal infections (Blooi et al., 2015a). The main
disadvantage linked to temperature treatment is that elevated temperature might not be endured by
all salamander species, and may result in thermal shock. The occurrence of Bsal in (sub)tropical
regions such as Okinawa (Japan) and northern Vietnam at temperatures above 25°C suggests the
existence of Bsal strains with higher thermal tolerance (Laking et al., 2017). It might therefore be
possible, that some Bsal strains could survive heat treatment at 25°C, although this has not been
reported so far. Currently, there is no evidence of the presence of heat-resistant strains in Europe.
Heat treatment can be applied to the thermo-tolerant species of salamanders (e.g. Triturus
dobrogicus, Ommatotriton vittatus, Salamandra immaculata, Cynops orientalis, Paramesotriton
hongkongensis and Salamandra salamandra; see details and references in Blooi et al., 2015a; EFSA
AHAW Panel, 2017; An Martel and Frank Pasmans, University of Ghent, personal communication,
2018), also as a preventative measure.
Bsal in salamanders
www.efsa.europa.eu/efsajournal 24 EFSA Journal 2018;16(4):5259
Treatment with antimicrobials
For the species of salamanders that are not thermotolerant, an alternative treatment is combining
the topical spray application twice/day of voriconazole (12.5 lg/mL) with polymyxin E (colistin)
submersion bath (2,000 IU/mL) and keeping the infected salamanders at 20°C for 10 days (Blooi
et al., 2015b), whereas the antimicrobial treatment at an ambient treatment of 15°C failed to clear
Bsal (Blooi et al., 2015b) (for other details see also EFSA AHAW Panel, 2017). In one rare example of
ﬁeld treatment of anurans, sporadic application of antifungal agents was not sufﬁcient for the long-
term and large-scale control of Bd (Geiger et al., 2017). Unintended side-effects also need to be
evaluated; for example, Rohr et al. (2017) reported that antifungal treatments considered effective for
killing Bd in culture may not be effective on wild amphibians and in some cases could exacerbate
Bd-induced mortality.
Colistin is a polymyxin antibiotic that is considered as the ﬁnal line of treatment for multidrug-
resistant Gram-negative bacteria (Li et al.,2006) and exposure to colistin is associated with an
increased risk of isolating colistin-resistant Enterobacteriaceae (Drozdinsky et al., 2017). Also the use
of azoles-based antifungals (the most frequently used classes of antifungal therapy) may induce
resistance in fungi (Fuentefria et al., 2017). Therefore, the preventative use of these antimicrobials in
salamanders, which have not been conﬁrmed to be Bsal infected, cannot be justiﬁed.
For those species that are thermotolerant, heat treatment is the preferred option; however,
information about thermotolerance for individual species is incomplete.
3.2.2. Risk of survival, spread and establishment of Bsal within already infected
areas and spread from infected areas into other parts of the EU by natural
movements of wild live salamanders taking into account especially relevant
geographical, hydrographical and meteorological conditions (ToR 3a–i)
From a biological point of view, the geographical unit can be deﬁned as a patch of suitable habitats
inhabited by the species in question.
For salamanders, deﬁning the relevant geographical unit is difﬁcult because many aspects are not
known, and there is great variability among the species of salamanders. Based on the few data
available and the experts’ knowledge, it is suggested that, in most species, sites of occurrence
separated by unsuitable habitat at a distance above 1 km can be considered as separate local
populations with respect to pathogen spread.
At this moment, it is not known if the outbreaks that occurred in the EU in wild salamander
populations were somehow linked; there is a lack of knowledge about the possible sources of
pathogen contamination within the different Bsal-positive sites. Some studies are currently carried out
in the south of Belgium. Areas where Bsal has been detected are relatively close, in a speciﬁc region
(although in three countries: BE, DE, NL) and are sites frequented by people including those interested
in salamanders. This might suggest a possible route of introduction from one site to another (or
several introduction events, to be shown by genetics studies).
Direct Bsal transmission can occur between individuals of the same species of salamanders
(intraspecies: Martel et al., 2013), of different salamanders’ species (interspecies: Martel et al., 2014)
or between anurans and salamander species (Stegen et al., 2017).
The capability of Bsal to be transmitted directly via infected animal contacts, or indirectly via
healthy carrier animals by encysted spores, motile zoospores or contaminated soil has been already
reported (EFSA AHAW Panel, 2017).
Several carriers could have a role in transmitting Bsal to salamanders: e.g. Bsal adherence of
spores on goose feet have been shown experimentally (Stegen et al., 2017). Also, frogs and toads
could be Bsal carriers (Nguyen et al., 2017; Stegen et al., 2017) and these amphibians can move from
hundreds of metres up to several kilometres during migrations (Tunner, 1991; Kovar et al., 2009). In
addition, waterfowl carrying spores of the sister species Bd on skin or feathers have been reported
(Wimsatt et al., 2014).
Bsal produces two types of spores (see Figure 4). The motile ‘spores’ actively swim in water
searching for host skin, and they are predated upon by zooplankton. The ‘encysted non-motile spores’
are resilient and thick-walled; they ﬂoat, remain infective for at least a month in water and are more
resistant to predation by zooplankton. Bsal present in wet soil remained infective up to 48 h after the
soil was contaminated by an infected salamander (Stegen et al., 2017). The fungus can survive on
subclinically infected salamanders and frogs for several months and these can act as active or passive
carriers (Martel et al., 2014; Stegen et al., 2017).
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Among all the possible means of Bsal spread, the ones that, depending on the scenario, were
considered as the ‘top three means’ by the experts are listed below, with a short explanation of the
rationale behind the result of the qualitative categorisation. As explained in Section 3.2.4, the
contributors to Bsal spread can act as carriers of the fungus.
Scenario A – Main contributors to Bsal spread and survival in an infected area within a
subpopulation:
• Salamanders intraspecies: individuals of the same species have a high role in actively
transmitting Bsal because they have high probability to meet and interact (mating,
hibernation), even more so than between different salamander species.
• Salamanders interspecies: direct Bsal transmission between individuals of different species can
also be relevant. However, there is variability in the susceptibility to Bsal among different
species.
• Frogs and toads (Anura): Bsal has been experimentally shown to be transmitted directly from
an anuran species to salamanders, and Bsal has been found to be naturally present in one
anuran species. However, the contribution of this means of transmission of Bsal to salamanders
has been ranked less probable by the experts because it has not been fully studied: e.g. it is
not known if other anuran species may be active or passive carriers of Bsal. In addition, the
probability that salamanders come in contact or interact with anurans is lower compared with
intra-species or inter-species interactions among salamanders.
Scenario B – Main contributors for the spread of Bsal from an infected area to an
uninfected area, between subpopulations of the same meta-population:
• Amphibian-related human activities: people (and related equipment) that during speciﬁc
amphibian-related activities, e.g. for research purposes, may enter in contact with infected
salamanders or their habitat and may move from one site to another even in a short time and
over long distances. Transport of salamanders for conservation purposes, assisted dispersal
and reintroductions can also be important processes in Bsal spread.
Figure 4: Description of the possible means for Bsal environmental persistence and spread in the wild
(see also description of the means of spread in the text below) (Reprinted by permission
from: Springer Nature, Nature, In peril from a perfect pathogen, Fisher, ©2017)
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• Wild birds: movement of wild birds carrying spores can transmit Bsal from an infected area to
uninfected areas because of the long distance that they can reach in a short time and due to
the experimentally conﬁrmed ability of spores to stick to bird’s feet.
• Salamanders interspecies: infected individuals of a species with higher ability to cross
unsuitable habitat or species transported (e.g. by ﬂood, human activities) to new sites, can
support spread from an infected site to a new one.
Scenario C – Main contributors for the entry of Bsal from an infected area to an
uninfected area across geography barriers between meta-populations:
• Wild birds: movement of wild birds carrying spores can transmit Bsal between meta-populations
(also across geographical barriers) because of the long distance they can ﬂy in a short time.
• Amphibian-related human activities: people (and related equipment) that for speciﬁc
amphibian-related activities, e.g. for research studies, may enter into contact with infected
salamanders or their habitat, and may move from one site to another even in a short time and
for long distances.
• Non-amphibian-related human activities: Bsal spores may attach to equipment used for other
activities (e.g. ﬁshing, forestry) in Bsal-infected environments (e.g. water bodies). However,
these human movements are less linked to the salamander-inhabited microhabitat compared
with the amphibian-related human activities.
The following means have also been identiﬁed by the experts as possible carriers (mainly passive
ones) of Bsal (see Table 2) and have been scored high (even without being a part of the ‘top three’) in
one of more scenarios, for the following reasons:
• Water: for aquatic and semi-aquatic salamander species, water may be an important means of
transmitting Bsal zoospores from an infected individual to an uninfected one. In addition,
zoospores may survive up to 31 days in the water. In scenario B, water was scored as
probable if water streams are connected (see Table 2). If no connection exists, this means was
considered improbable to have a role in Bsal transmission.
• Substrate: Bsal has been detected in naturally contaminated soil, and the role of infected soil
in transmitting Bsal to uninfected salamanders has been demonstrated. In addition, Bsal-
contaminated soil remained infective up to two days after exposure to infected salamanders.
• Wild mammals: Bsal spores may attach to mammals entering infected waterbodies and
environments. In addition, some wild mammals (e.g. racoons, otters, minks) prey on amphibians
and, therefore, may have direct contact with infected salamanders. Wild mammals can move for
relatively long distances (within geographical barriers) and may contaminate uninfected areas (e.g.
water bodies). However, currently there is no evidence of spores’ transmission via wild mammals.
Reptiles, ﬁsh and invertebrates have been also identiﬁed as possible means of Bsal spread (see
Table 2); however, they have been considered less important in the Bsal transmission for the following
reasons: evidence of spores’ transmission is available for Bd only and these means of spread cannot
reach long distances between salamanders’ subpopulations or meta-populations. In addition, ﬁsh are
strictly linked to the aquatic environment and cannot be in contact with terrestrial salamander species
(e.g. Speleomantes sp., Salamandra atra). Reptiles are present in both aquatic and terrestrial
environments; however the dehydration and increase in temperature that they experience when they
heat up under the sun, are not favourable to Bsal survival.
In conclusion, according to the experts’ judgement on risk factor ranking, the risk of Bsal spread in an
infected population is maintained by intra-species contact of salamanders or potentially salamander
interspecies and interamphibian interactions. Entry into new areas and populations is most likely to be
caused by human activities (mainly amphibian-related) and potentially by wild birds (and by wild mammals
and connected streams of water that carry Bsal between subpopulations of the same meta-populations),
all of which are characterised by the possibility of long-distance movements and transmission.
In the following Table 2, the means of Bsal spread identiﬁed by the experts have been reported
together with a short description/explanation and reference to the available evidence for a possible
Bsal transport (if any). When no evidence supporting a possible Bsal transmission was available,
reference to available studies on Bd have been added, because they have been shown to be close
enough to allow some generalisations for basic biological aspects for both species of the genus
Batrachochytrium (for more details, see EFSA, 2017). The experts’ qualitative assessment of each
means has also been included in the table.
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Table 2: Possible means of Bsal spread in the salamanders’ natural habitat and the experts’ categorisation(*)
Possible
means of
Bsal spread
Description/explanation
Available evidence for
Bsal or, if not available,
for Bd
Ranking category assigned
to the particular means
considering its potential to
spread the pathogen within
a subpopulation
Ranking category assigned
to the particular means
considering its potential to
spread the pathogen
between subpopulations of
the same meta-population
Ranking category assigned
to the particular means
considering its potential
to spread the pathogen
between meta-populations
Salamanders
intraspecies
(active
carriers)
Direct random contact or
contamination of the
shared environment
Mating, ﬁghting,
overwintering, migration
routes
Experimental evidence in
co-housed salamanders
(Martel et al., 2013)
A B (compared with anurans:
salamanders have higher
infection loads, but they move
less)
C
Salamanders
inter-species
(active
carriers)
Direct random contact or
contamination of the
shared environment.
Predation, overwintering,
migration routes
Experimental evidence In
co-housed salamanders
(Martel et al., 2014; Stegen
et al., 2017)
Aa Ab C
Frogs and
toads (active/
passive
carriers)
Direct random contact or
contamination of the
shared environment
Predatory interactions
(salamanders feeding on
frog larvae), overwintering
sites, migration
Experimental evidence of
Alytes obstetricans
transmitting Bsal to
salamanders (Stegen et al.,
2017)
Natural presence of Bsal in
Bombina microdeladigitora
(Nguyen et al., 2017)
Ab B (compared with salamanders:
anurans have a lower infection
loads, but they can move more)
C
Wild birds
(passive
carriers)
Attachment of spores on
waterfowl and possible
contamination of water
bodies
For Bsal: Experimental
adherence on goose feet
(Stegen et al., 2017)
For Bd: Feathers and feet
of waterfowl in
experimental and natural
conditions (Johnson and
Speare, 2005; Garmyn
et al., 2012; Wimsatt et al.,
2014; Hanlon et al., 2017)
B A A
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Possible
means of
Bsal spread
Description/explanation
Available evidence for
Bsal or, if not available,
for Bd
Ranking category assigned
to the particular means
considering its potential to
spread the pathogen within
a subpopulation
Ranking category assigned
to the particular means
considering its potential to
spread the pathogen
between subpopulations of
the same meta-population
Ranking category assigned
to the particular means
considering its potential
to spread the pathogen
between meta-populations
Wild
mammals
(e.g. wild
boars, racoon-
dog, mink,
otter)
(passive
carriers)
Attachment of spores on
mammals visiting infected
waterbodies, amphibian
predators. Contamination
of water bodies
From experts opinion B Ab Bb
Water
(passive
carriers)
Motile zoospores and non-
motile spores in
contaminated water
Bsal: Experimental
infections with water
containing zoospores,
survival of zoospores
(Martel et al., 2013, 2014;
Stegen et al., 2017)
Ac Ac if streams are connected; C
if there is no connection
C (except for downstream: B)
Substrate
(passive
carriers)
Tracks of moving infected
individuals, sites of
mortality, contaminated soil
as source of infection
Experimental infection with
infected soil (Stegen et al.,
2017)
Detection of Bsal naturally
contaminated soil (Stegen
et al., 2017)
Ac Not applicable (NA; because it
is related to human
movements)
NA (because it is related to
human movements)
Amphibian-
related
human
activities
(passive
carriers)
Movement of all above-
mentioned means of
transport (release of
amphibians, movement of
amphibians in
conservation/research,
aquaculture, ornamental
ponds, etc.) due to human
movements and equipment
(e.g. boots) related to
activities speciﬁcally linked
to amphibians or their
habitats (e.g. scientists)
For Bsal: Zhu et al. (2014)
For Bd: The presence in
farmed and human
introduced invasive species
(e.g. Fisher and Garner,
2007; Fisher et al., 2009;
Reeder et al., 2012), in
reintroduction programmes
(Walker et al., 2008)
In sold amphibians as
ﬁshing bait in USA (Picco
and Collins, 2008);
however, this practice is
not common practice in EU
B A A
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Possible
means of
Bsal spread
Description/explanation
Available evidence for
Bsal or, if not available,
for Bd
Ranking category assigned
to the particular means
considering its potential to
spread the pathogen within
a subpopulation
Ranking category assigned
to the particular means
considering its potential to
spread the pathogen
between subpopulations of
the same meta-population
Ranking category assigned
to the particular means
considering its potential
to spread the pathogen
between meta-populations
Not
amphibian-
related
human
activities
(passive
carriers)
Human movements and
equipment not speciﬁcally
related to amphibians
(forestry, agriculture,
hunting, ﬁshing, sports,
etc.) that by change get in
contact with a
contaminated source and
transport Bsal spores
These activities can cause
changes in amphibian
population, movement,
water ﬂow, etc.
From experts opinion Ba B B
Reptiles Random attachment and
transmission of spores on
surface of reptiles (e.g.
lizards, snakes, turtles)
Not for Bsal
For Bd: attachment on
reptilian skin (Kilburn et al.,
2011)
B C C
Fish Infection of ﬁsh Not for Bsal
For Bd: Experimental
infection of zebraﬁsh
larvae, but no detection in
wild ﬁsh (Liew et al., 2017)
B C C
Invertebrates Infection or passive
carriers,
Not for Bsal
For Bd: Crayﬁsh species in
USA (McMahon et al.,
2013)
B B C
(*): All means were ranked by their relevance for spread of Bsal in wild live salamanders and put in three different categories dependent on the following scenarios of spread: (i) within a
subpopulation, (ii) from an infected area to an uninfected area between subpopulations of the same meta-population, and (iii) from an infected area to an uninfected area across geographical
barriers (between meta-populations), by using a consensus discussion with categories from ‘A’ to ‘C’ which were coloured differently; ‘A’ (coloured in light blue) represents means that were
categorised as most relevant for Bsal spread in a certain scenario, whereas ‘B’ and ‘C’ (coloured in yellow and red, respectively) were categorised of lower importance. If necessary,
subcategories were introduced to express within category differences using small letters: a, b and c.
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3.2.3. Risk-mitigating measures that could potentially be effective in ensuring
safer international or intra-EU trade of live salamanders (both captured
in the wild and bred) and their products and by-products as regards the
transmission or Bsal, including diagnosis and potential treatment(s)
(ToR 3b)
3.2.3.1. Possible salamander products and by-products
Salamander products and by-products are not known to be produced in the EU. Although in Asia,
and particularly in China, there is a considerable use of newts and salamanders in traditional oriental
medicine and for human consumption, no data are available to support the possibility that live Caudata
or their (by-)products are being imported into the EU for these speciﬁc purposes (Tracey King,
Ornamental Aquatic Trade Association Ltd, personal communication, 2018); however, the possibility
that they might be imported for satisfying a niche of speciﬁc (mainly Asian) customers cannot be
excluded.
In general, salamander species are of marginal importance for food consumption or other
purposes, with single species as an exception: China has developed an intense giant salamander
(Andrias davidianus) farming industry in recent years, with over 2.6 million animals held in ofﬁcial
farms in 2011. The farms have limited if any biosecurity measures against introduction and spread of
infectious disease. There are economic pressures on the provincial and national governments to
remove the protected status of the species and to simplify licensing for the sale of Chinese giant
salamanders and their products (Cunningham et al., 2016). The farms attempt to sell their products
internationally, also online.17 Andrias davidianus is a CITES (Convention on International Trade in
Endangered Species)18 listed species, therefore, the movements of this species are regulated. At
present time there is no knowledge about importation of Andrias davidianus meat into EU. Data on
Bsal infections in the species are missing, therefore the potential of Bsal spread by the salamander
farming industry and its products is unclear.
In addition, even if illegal movements may exist, the experts consider it unlikely that the meat,
which is produced for human consumption, would enter in contact with live salamanders or any
aquatic environment within the EU. Therefore, the possibility that this product poses a threat to EU
populations of salamanders is considered negligible.
Traditional oriental medicine
The skin, maw and bladder of salamanders (e.g. of Andrias davidianus; Still, 2003) are used in
numerous remedies in China for the traditional oriental medicine.19 These animal by-products, however,
derive from salamanders that have been heat treated at 25°C and desiccated. Therefore, they are not
considered relevant for the potential spread of Bsal to the salamander populations in the EU.
Other by-products of amphibians such as leather or poison do not pose a threat of Bsal
transmission as they are heat treated or dried (e.g. leather) or are not usually imported into the EU
(e.g. poison).
Salamanders used as ﬁsh-baits:
Information exist on the trade of live salamanders used as ﬁshing baits in some areas of the north
of the USA (Picco and Collins, 2008), however there is no evidence of this practice being used in
Europe and in some EU MSs it is likely prevented by national laws on species conservation and against
cruelty to animals (CZ, DE, IR).
Considering the above reported information, it is concluded that heat treatment or desiccation of
salamander products and by-products is feasible and effective to ensure safe international and intra-EU
trade. Therefore, it was not considered relevant to include salamander products and by-products in the
assessment reported in Table 3.
17 For example: http://www.e-cantonfair.com/products/giant-salamander-meat-792802.html: Chinese company that is selling
Chinese products online.
18 https://www.cites.org/eng
19 http://www.sciencedirect.com/science/article/pii/S0965229903000554
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3.2.3.2. Description of how live salamanders are transported in international or intra-EU
movements
Most traded salamanders are shipped as adults or metamorphosed juveniles. Even if it is possible, it is
unlikely that larval stage of Caudata, other than axolotls (Ambystoma mexicanum), is traded commercially
within the EU. Other than axolotls, the only larval species that it is known to have been commercially
traded is neotenic tiger salamanders (Ambystoma tigrinum) originating from the USA. However, there is
no evidence that such commercial trade in neotenic tiger salamanders has taken place within the last
10 years (Tracey King, Ornamental Aquatic Trade Association Ltd, personal communication, 2018).
For international import to the EU, the transport of salamanders normally takes place by air, and,
according to the current legislation (Council Regulation (EC) 1/200520) the transport by air should
comply with the International Air Transport Association (IATA) Live Animal Regulations (LAR)21
standards for transportation of live animals.
For intra-EU movements, the transport may occur on road-vehicles under conditions that may vary
according to several factors, e.g. distances, species, amount of animals (Paul Bakuwel, Ornamental
Fish International, personal communication, 2018). When transported, salamanders are included in
primary containers, which are different for aquatic or terrestrial species. The small perforated plastic
boxes for the terrestrial species are ﬁlled with wet substrate (sphagnum moss, ﬁlter ﬁbres, paper
towels, etc.). The substrate maintains high humidity and protects the animal from injury. The container
is placed in a cardboard box and an insulation box, to protect the animal from mechanical and thermal
stress. If there is high ambient temperatures during transport, cooling with ice or cool gel packs is
recommended. Primary containers of aquatic species are double plastic bags ﬁlled with water and a
mixture of oxygen and air. Eggs or larvae of some aquatic species (e.g. Ambystoma mexicanum) are
shipped in containers (or breather bags allowing oxygen diffusion) completely ﬁlled with clean water,
without any substrate or plants, or on wet towels.22
In the primary containers, Caudata, would typically be packed individually or in small groups of the
same species and it is generally considered poor practice to pack mixed species in primary containers.
The primary containers are then included in secondary containers (e.g. polystyrene boxes that can be
reused after cleaning and disinfection), which might contain primary containers with Caudata of different
species or it is even possible that Caudata and anurans could be packed into the same secondary
container. The number of animals for each shipment may vary depending on the species that are
transported (Tracey King, Ornamental Aquatic Trade Association Ltd, personal communication, 2018).
The procedures followed for the transportation of salamanders in small-scale trade among keepers
and breeders vary depending on the biology and price of the species, but also on the experience of
the sender.
Ofﬁcial data on salamanders’ import and intra-EU movements are very limited and concern the
import of CITES-listed species only; these data are considered to be only a low percentage of the total
volume (for an overview on salamanders’ trade, see EFSA, 2017). The lack of quantitative ofﬁcial and
harmonised data is also due to the lack of a unique commodity code for identifying salamanders, and
amphibians in general (EFSA, 2017; EFSA AHAW Panel, 2017).
Other forms of salamander exchange
The trade of captive salamanders is not performed only by ofﬁcial shops and traders.
For Caudata which are traded (i.e. brought, sold, exchanged) between hobbyists, it is likely that
‘trade’ in larval Caudata occurs. It is extremely likely that such animals are captive bred by hobbyists
and, as such, the hobbyists will know each other, and it could be expected that the provenance of
these animals will be known (Tracey King, Ornamental Aquatic Trade Association Ltd, personal
communication, 2018). A community of amphibian enthusiasts is active in sharing and trading captive
salamanders. This segment of trade is very difﬁcult to quantify as it operates on a ‘peer to peer’ basis,
facilitated by social media, Internet fora and discussion groups.
A simple search on the single social networking service ‘Facebook’23 (on January 2018, search
word: ‘salamanders’) shows over 20 closed groups specialised in captive salamander husbandry and
20 Council Regulation (EC) No 1/2005 of 22 December 2004 on the protection of animals during transport and related operations
and amending Directives 64/432/EEC and 93/119/EC and Regulation (EC) No 1255/97.
21 http://www.iata.org/publications/store/Pages/live-animals-regulations.aspx
22 http://www.caudata.org/cc/articles/shipping.shtm
23 https://www.facebook.com/
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trading, with many of them based within the EU. The size of these groups ranges from several
hundred up to over 20,000 members.
Another option for non-centralised trade-ﬂow happens at exotic pet trade shows. The number of
salamanders transported via the community is large in both individuals and species. The biodiversity of
captive traded salamanders is very high; the easily kept species like axolotl (Ambystoma mexicanum) or
sharp-ribbed salamander (Pleurodeles waltl) are the most common. Even rare species, species new to
science, or those with restricted distribution, can be obtained through social media or fairs: e.g.
Laotriton laonensis from northern Laos, zoologically described in 2002 (Stuart and Papenfuss, 2002) is
nationally protected but became a popular species with well described husbandry (Bachhausen, 2017);
Paramesotriton guanxiensis, rare species with small area of occupancy in southern China (IUCN Red List;
Huang et al., 1983); or the Mangshan crocodile newt, Tylototriton lizhenchangi, from China described in
2012 (Hou et al., 2012). Some salamanders are bartered between keepers, some common species can
be found almost free of charge for beginning keepers, whereas the price for rare, speciﬁc species or
unusual individuals reaches up to hundreds of euros. The hobbyist trade of salamanders is in general
based on licences and certiﬁcates of captive bred status depending on the national legislation, which
may differ among MSs. Movement of rare and protected species is more difﬁcult to trace. However,
attempts to place formal restrictions on trade ban in salamanders would likely cause a large proportion of
the community going underground and boosting the illegal trade. The community can easily be reached
by the social media on which it operates. If support to Bsal prevention is easily available, most
salamander keepers are likely to be motivated to follow the guidelines to safeguard their captive animals.
3.2.3.3. Risk-mitigating measures that could potentially be effective in ensuring safer
international or intra-EU trade of live salamanders
The list of mitigation measures considered relevant for international and intra-EU movements of live
salamanders described by EFSA (2017) has been revised on the basis of new available knowledge, and
on the feasibility and effectiveness of the measures (see Section 2.2.4).
In the context of this scientiﬁc opinion, the risk-mitigation measures that have been taken into
account are the measures that can be applied pre-emptively. In addition, it has to be highlighted that
the expert assessment refers only to compliant behaviours.
The possible risk-mitigation measures that could potentially be effective in reducing Bsal risk in
international or intra-EU trade of live salamanders, as identiﬁed by the experts, are listed and
described below (see also Table 3).
The following measures prevent introduction of Bsal by increasing stringency:
• Preventative treatment:
Treating salamanders preventatively before moving is a measure that the experts consider relevant
for heat treatment (see Section 3.2.1.2), whereas the preventative use of antimicrobials (antibiotics
and antifungals) in salamanders, which have not been conﬁrmed to be Bsal infected, was not
considered justiﬁable. Feasibility of heat treatment was scored from 3 to 5, only if applied to heat-
tolerant species of salamanders (e.g. Triturus dobrogicus, Ommatotriton vittatus, Salamandra
immaculata, Cynops orientalis, Paramesotriton hongkongensis and Salamandra salamandra). For these
species, the effectiveness was scored from 4.5 to 5. An additional aspect highlighted by the experts is
that heat treatment can be applied to groups of salamanders and not only individually. Experts noted
that heat tolerance has not been assessed across all salamander species.
• Quarantine24:
Quarantine consists of keeping traded salamanders in tanks at the entrance point for 6 weeks,
which is the whole Bsal incubation time for Salamandra salamandra. Testing the animals for Bsal (in
accordance with the protocol reported in Section 3.1.2.1) should take place over the last week of the
quarantine. The following actions (release to the destination or treatment of the animals) will be put in
place on the basis of the results of the test. Quarantine is reported as a relevant management action
(Langwig et al., 2015). However, it requires that proper procedures and facilities are in place at each
entry point. The experts scored 4 on the feasibility of this measure, which may vary on the basis of
the traded volume, and from 3.5 to 5 on its effectiveness. Comparable quarantine measure should be
applied also for intra-EU movements if the animals come from facilities that are not recognised as Bsal-
free (see Section 3.1.2.2).
24 In the meantime, Commission Implementing Decision 2018/320 has been published, describing quarantine rules.
Bsal in salamanders
www.efsa.europa.eu/efsajournal 33 EFSA Journal 2018;16(4):5259
• Premovement health certiﬁcation:
Salamanders showing Bsal clinical signs (skin lesions and ulcers) should not been transported. A
premovement health certiﬁcation25 should report that the salamanders have been individually tested
for Bsal (according to the protocol reported in Section 3.1.2.1) before being transported. Animals that
are Bsal positive should be properly treated (see Section 3.2.1.2). The validity of the health certiﬁcate
is commonly speciﬁed to 10 days; during this period of time the animals should not be in contact with
other amphibians. The experts scored the feasibility of this measure from 3 to 5 and its effectiveness
from 4 to 5, taking into account the high variability of the place of origin of the salamanders.
• Bsal testing at the entry point:
This consists of keeping traded salamanders in tanks at the entrance point for one week only,
which is the approximate time needed to carry out the Bsal testing (protocol in Section 3.1.2.1). Bsal-
positive animals should then be treated according to protocols explained in Section 3.2.1.1. Ideally, all
salamanders already kept in captivity in the EU should be Bsal negative (which can be achieved by
large-scale screening and treatment, see Section 3.1.2.2) and, therefore, ready to be moved intra-EU.
In addition, all live salamanders entering the EU should be tested. The experts scored from 3 to 5 on
both the feasibility and the effectiveness of this measure, noting that it does not take into
consideration the possible Bsal incubation time which may vary for different species.
• Restriction on salamander importation:
This measure has been set up in the USA in 2016, for 201 species of salamander26 and in Hungary
in 2017, for any species of the families Hynobiidae and Salamandridae, and for individuals of the
species Karsenia koreana (pertaining to the family Plethodontidae).27 The restriction on salamander
introduction on the basis of their origin (e.g. from countries where presence of Bsal has been proven)
or for some salamander families is a possibility that the experts judged highly feasible (5) and effective
(from 4 to 5); however, a clear deﬁnition of the restriction criteria and parameters (which countries,
which families, which species) needs to be based on progress in the knowledge on Bsal.
• Ban on the importation of salamanders:
A ban on salamander movements at the level of taxonomic order has been considered in EFSA
(2017) as depending on the import volumes. In the context of this scientiﬁc opinion, this measure has
been judged by the experts as a feasible (5) and effective (from 4 to 5) way to prevent introducing
Bsal in new areas due to movements of salamanders. However, it needs to be considered that a ban
on salamander movements into the EU or intra-EU may boost illegal trade.
The following measures prevent introduction of Bsal when the animals are moved in the EU
(irrespective if they originate from a third Country or an EU MS):
• Tracking all traded species:
Current trade records are not complete for species and other import/intra-EU movement data.
Therefore, it is considered important to implement a harmonised system for identifying a commodity
code for the amphibians (for each shipment) and for tracing the animals that are moved. The experts
judged it as a feasible measure (from 4 to 5). Due to the fact that it is related to the host and not to
the pathogen, its effectiveness in preventing the spread of Bsal was considered low (score from 1 to
2); however, it was recognised to be useful in tracing back other possibly infected animals.
• Hygiene procedures:
To minimise the potential of Bsal spread, appropriate cleaning and disinfection (see Section 3.2.1.1)
of equipment that enters into contact with salamanders (e.g. transport containers, manipulation
equipment or boxes for trade) should be applied, before loading the animals, reuse and disposal.
25 In the meantime, Commission Implementing Decision 2018/320 has been published, describing the health certiﬁcate.
26 US Federal Register/Vol. 81 No. 8, 13 January 2016 – Rules and Regulations, Fish and Wildlife Service (50 CFR Part16);
available at: https://www.fws.gov/policy/library/2016/2016-00452.pdf
27 Hungarian Government Decree 199/2017: 199/2017. (VII. 10.) Korm. Rendelet a kedvtelesb}ol tartott allatok tartasarol es
forgalmazasarol szolo 41/2010. (II. 26.) Korm. rendelet es a veszelyeztetett vadon el}o allat- es n€ovenyfajok nemzetk€ozi
kereskedelmet szabalyozo nemzetk€ozi es europai k€oz€ossegi jogi aktusok vegrehajtasanak egyes szabalyairol szolo 292/2008.
(XII. 10.) Korm. rendelet modosıtasarol; available at: https://net.jogtar.hu/jogszabaly?docid=A1700199.KOR&timeshift=fffffff
4&txtreferer=00000001.TXT
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Commodities that are traded with the animals (e.g. water, substrate, soil, plants) should be cleaned
and disinfected or safely disposed of. This measure was scored from 4 to 5 in feasibility and 5 in
effectiveness.
• Good practice manuals:
The application of good practices was considered relevant in preventing the introduction of Bsal
and, therefore, ensuring safe movements of salamanders. This measure consists of setting up a good
practice code containing guidelines that should be followed by traders (e.g. the use of cleaned and
disinfected boxes, plastic bags for transporting the animals, the use of disposable gloves when
handling individual batches, disinfect the water before disposal, if there is organic substrate to
incinerate it). The feasibility of this measure was judged 5 and its effectiveness from 4 to 5.
• Application of probiotics to salamanders:
This measure consists of applying microbiota on the skin of the salamanders that are transported.
Evidence on the use of probiotics has been reported from laboratory studies, but so far it has not been
demonstrated under ﬁeld conditions. As the information on the use of any probiotic to control Bsal
infection is limited, the experts considered this option to be of low feasibility (1–2) and effectiveness
(1–2).
In addition, ‘vaccination of salamanders’ has also been discussed by the experts. In principle, this
measure would consist in immunising salamanders with Bsal or related antigens to stimulate a
protective response. However, no vaccines have been developed for amphibians (not even for Bd in
anurans) and it is still not clear whether induction of a protective immune response in amphibians
occurs. Even if studies have been carried out, no immune reaction has been demonstrated in
salamanders for Bsal: repeated infection–treatment cycles in Caudata did not induce any signiﬁcant
protection against Bsal infection (Stegen et al., 2017). Immune dampening by Bsal has been reported
in a recent publication as highly likely (Farrer et al., 2017). For these reasons the experts excluded this
option from the possible risk-mitigation measures.
The best way to ensure safe salamander movements is considered to be a combination of several
of the above-mentioned possible measures, for instance import or movement restrictions, entry tests
and good practice. In addition to their expected effect in Bsal risk mitigation, other pathogens (e.g.
viruses) are still spreading and some may currently be excluded by geographic barriers. Hence,
biosecurity still has the potential to mitigate spread of undiscovered and unpredictable pathogens of
wildlife (Berger et al., 2016; Richgels et al., 2016).
In conclusion, according to the experts’ judgement, banning the import of salamanders or
restricting the ban to speciﬁc families/genera/species or to speciﬁc countries of origin (i.e. where Bsal
has been proven) and quarantine (plus Bsal testing) are considered possible measures for ensuring
safer international movements. However, their feasibility and effectiveness depend on the volumes of
animals that are transported. Banning/restricting trade might also boost illegal movements. An
alternative that the experts consider likely to minimise the risk of spreading disease, consists of a
combination of best practices and hygiene procedures that minimise importation and intra-EU
movements of infected animals. In addition, movements only from captive bred stocks for which the
health status is known (‘close populations’), should be fostered (see also Section 3.1.2.2).
In Table 3, the risk-mitigation measures identiﬁed by the experts to ensure safer international or
intra-EU movements of live salamanders have been listed, together with a short description/
explanation and reference. The results of the experts’ qualitative assessments of their feasibility and
effectiveness have been also reported (for the details on the methodology and a full description of the
results, see Section 2.2.4 and Appendix C (Section C.3)).
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Figure 5 summarises the feasibility x effectiveness assessment of risk-mitigation measures that
could potentially be effective in ensuring safer international or intra-EU trade of live salamanders,
revealing their relationship on a feasibility (x-axis) vs effectiveness (y-axis) plane. No measure was
considered certainly perfectly feasible and effective. ‘Hygiene procedures’, ‘GP manuals’ and ‘trade ban
Table 3: Risk-mitigation measures that could potentially be effective in ensuring safer international
or intra-EU trade of live salamanders as regards the transmission or Bsal, including
diagnosis and potential treatment (s) and qualitative assessment of their feasibility and
effectiveness (*) – based on Table 7 in EFSA (2017)
Risk-mitigation
measures(a)
Deﬁnition/explanation
Score for feasibility
considering also the
consequences (e.g.
environment)
Score for
effectiveness
Preventative heat
treatment
To treat animals in an environment at 25°C for
10 days (see Section 3.2.1.2)
3–5 4.5–5
Quarantine Previously reported in Grant et al. (2016, 2017)
Keep traded salamanders in tanks at entrance
point for the whole Bsal incubation time while
testing them for Bsal (see Section 3.1.2.1) over
the last week
4 3.5–5
Require pre-
movement health
certiﬁcation
Previously reported in Grant et al. (2016, 2017)
Individual Bsal test of salamanders (see
Section 3.1.2.1)
3–5 4–5
Bsal testing at the
entry point
Keep traded salamanders in tanks at entrance
point while individual testing for Bsal (see
Section 3.1.2.1)
Positive animals will be treated (according to
protocols explained in Section 3.2.1.1)
3–5 3–5
Restrict
importation
of some
salamanders
Previously reported in Grant et al. (2016, 2017)
Restrictions/partial ban of salamander
introduction on the basis of the origin or for
some salamander families
5 4–5
Ban all
importation of
salamanders
Previously reported in Grant et al. (2016, 2017)
Ban of all salamanders trade (Martel et al.,
2014; Yap et al., 2015; Berger et al., 2016;
Richgels et al., 2016)
5 4–5
Tracking all
traded species
Use an unique code for identifying salamanders’
(or amphibians’ in general) shipments (Auliya
et al., 2016; EFSA, 2017)
4–5 1–2
Hygiene
procedures
Equipment that enters in contact with
salamanders should be cleaned and disinfected
(according to the protocols reported in
Section 3.2.1) (EFSA, 2017)
4–5 5
Good practice
manuals
Draw up and distribute a good practice code
containing guidelines for traders for handling
salamanders and fomites (Murray et al., 2011b)
5 4–5
Apply probiotics
to salamanders
Previously reported in Grant et al. (2016, 2017)
Preventative probiotic in salamanders’ skin. The
method has not been drawn up for Bsal
Examples of studies on Bd are reviewed in Bletz
et al. (2013)
1–2 1–2
(*): The feasibility was assessed on a continuous scale from ‘least feasible’ to ‘most feasible’, integrating aspects related to
human resources, technical efforts, treatment costs and environmental side-effects and the effectiveness was assessed on a
continuous scale from ‘no prevention’ to ‘blocking measure’. After consensus appraisal of the outcomes of the individual
judgements (see Appendix C, Section C.3.1) and discussion of particular reasoning, the overall outcome was represented by
an interval covered by the central estimates across all experts. The quintiles of value distribution of judgements were
converted into a scale from 1 to 5. The broader is the reported interval, the greater is the uncertainty comprised in the
judgements.
(a): Grey cells indicate the risk-mitigating measures that the experts considered relevant to be added to the list reported in
Table 7 of EFSA (2017).
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and restrictions’ were considered promising on both scales. Other measures were attached with
greater uncertainty in either dimension, i.e. ‘preventative heat treatment’ and ‘pre-movement health
certiﬁcation’. Combinations of measures will improve effectiveness; feasibility may not increase due to
the combination of multiple efforts in implementation.
3.2.4. Role of live, silent carriers of Bsal in spreading it as vectors and those of
fomites (e.g. waste water, animal by-products, feed) and their risk-
mitigating measures (ToR 3c)
For this opinion, the carrier concept is interpreted as any means of spread (biotic and abiotic) of
Bsal potentially resulting in transmission to the host. It is differentiated to ‘active carriers’ (e.g.
salamanders, anurans) and ‘passive carriers’ (e.g. wild birds, water and human activities). Active
carriers are hosts acting as biological vectors for the spores, whereas passive carriers are mechanical
vectors to which the spores can be attached.
For this ToR, the Bsal-silent carrier concept refers to the passive carriers. Potentially, all the passive
carriers of Bsal listed in Table 2 for wild salamanders might be pertinent as silent carriers also for the
salamanders in captivity.
Here, only the ones for which evidence has been retrieved are listed and relevant risk-mitigation
measures provided.
3.2.4.1. Human movements, activities
Human-driven movements of amphibians and/or Bsal spores: e.g. human movements, or amphibian
movements through humans, for conservation or scientiﬁc purposes. Zhu et al. (2014), for example,
highlighted the need of using disposable latex gloves and to rinse boots and equipment with proper
disinfection solution before entering each location, to prevent cross-contamination among sites. In
general, deﬁned hygiene procedures and good practices when entering into contact with salamanders
and/or their habitats should be followed (see also following Sections 3.3.2 and 3.3.3).
Figure 5: Overview of the consensus judgement and uncertainty for feasibility and effectiveness of
the mitigation measures ensuring safer international or intra-EU trade of live salamanders
assessed by experts. For exact deﬁnition of feasibility and effectiveness used in the
judgement and individual level uncertainties see Appendix C (Section C.3). The branch
length in each dimension represents the remaining variability in central expert judgement
after consensus discussion (see Table 3). The areas under the curves have no meaning
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In addition, the release of new animals in a conservation site should be subjected to strict
biosecurity rules to prevent any contamination.
3.2.4.2. Water and waste water
Bsal zoospores have been shown to remain infectious in water for at least 31 days at 15°C (Stegen
et al., 2017); therefore, to minimise the potential of Bsal spread, appropriate treatment and
disinfection (see Section 3.2.1) of the water should be always performed before disposal or ﬂushing
down in the canalisation.
The use of tap water is also a safe measure.
3.2.4.3. Substrate
Soil has been shown to remain infective for at least 48 h (EFSA AHAW Panel, 2017; Stegen et al.,
2017); therefore, to minimise the potential of Bsal spread, appropriate treatment and disinfection (see
Section 3.2.1) of the substrate should be always performed before disposal.
The use of commercial substrate or pre-treatment of the substrate are also safe viable alternatives.
3.2.4.4. Equipment and fomites
Appropriate cleaning treatment and disinfection (see Section 3.2.1) of equipment and fomites that
are in contact with salamanders should be always performed before reusing them.
The use of disposable equipment is also a safe viable alternative.
3.2.4.5. Wild birds
Birds, particularly waterfowl, may carry chytrid spores (Hanlon et al., 2017). Bsal adherence on
goose feet has been proven experimentally (Stegen et al., 2017); therefore the role of birds in carrying
Bsal spores cannot be excluded.
It is reported (Paul Bakuwel, Ornamental Fish International, personal communication, 2018) that
kept salamanders are usually kept indoors; however, if outdoor facilities exist they need to be
protected from entrance of animals.
3.2.4.6. Anurans (frogs and toads)
Amphibians traded live or as chilled, unfrozen, unskinned legs are considered as potential carriers
of amphibian chytrids (Gratwicke et al., 2010). The knowledge on wild frog species as Bsal carriers is
limited to a single Asian species, Bombina microdeladigitora, a species that is not used in the food
trade (Nguyen et al., 2017).
Live anurans
Some species of anurans have been inoculated with Bsal and placed with salamanders: after
experimental exposure to Bsal, midwife toads (Alytes obstetricans) showed low intensities of Bsal for
several weeks. While the toads showed no sign of disease, their colonisation with the pathogen was
sufﬁcient to transmit Bsal to susceptible ﬁre salamanders (Stegen et al., 2017). Recently, wild and
traded, imported toads (Bombina microdeladigitora), presumably stemming from Vietnam, were found
to be positive for Bsal (Nguyen et al., 2017). Based on infection trials, healthy carriers may be
common in moderately susceptible European Caudata species as well (Stegen et al., 2017), in which
Bsal was demonstrated up to more than 3 months post exposure. As this long-term persistence did
not result in protection against re-infection, these species may prove suitable Bsal carriers for long
periods of times in infected ecosystems (Stegen et al., 2017).
As reported in Section 3.2.3.2, when amphibians are traded, it is possible that Caudata species and
anurans packed into different primary containers could be shipped into the same secondary container
(Tracey King, Ornamental Aquatic Trade Association Ltd, personal communication, 2018). However, if
the animals are transported following the correct hygiene procedures (see Section 3.2.3.3) and good
practices, the risk of contamination should be extremely unlikely (1–5% probability range; see EFSA
Guidance, 2018).
In addition, the load of Bsal in frogs is low, frogs are not infected in the skin and no speciﬁc test is
available with the sensitivity to detect Bsal. A possible presence of Bsal in frog’s larvae is unknown and
several anuran species have not been Bsal tested. Therefore, the role of anurans in carrying Bsal is still
unclear.
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Anuran products
Frogs’ legs are produced within and outside the EU, and meat for the Goliath frog is produced in
Cameroon. The most common amphibian product, frogs0 legs, is internationally traded and produced
by farming or by collection of amphibians in the wild. Belgium, France, Luxembourg and the
Netherlands have been the largest EU importers of frog meat in recent decades (Veith et al., 2000;
Warkentin et al., 2009; Altherr et al., 2011). The main exporters of frogs0 legs to the EU are from Asia:
Indonesia, Malaysia, China, and Vietnam (Warkentin et al., 2009; Altherr et al., 2011). The frogs0 legs
are most commonly traded skinned (skin removed) and frozen. This way of processing should be
sufﬁcient to inactivate chytrid fungi (tested on free-living species related to Batrachochytrium genus;
Gleason et al., 2008).
Anuran by-products
Frogs’ leather, poison of jungle frogs and exudation from the skin of certain frogs used as a
painkiller or as a poison are reported as by-products obtained by anurans. However, based on the
subjected treatments (heat treated or dried) and the low amount of production with very rare import
to the EU, the risk that they carry Bsal is considered negligible.
3.3. Protection from Bsal of kept and wild salamanders (ToR 4)
In general, as disease mitigation during outbreaks is unlikely to be successful, control efforts should
focus on preventing disease emergence and transmission between populations. So, this emerging wildlife
disease is best controlled through prevention rather than subsequent actions (Schmidt et al., 2017).
3.3.1. Protection of captive salamanders in the places where they are kept
3.3.1.1. Information on how the salamanders are kept in captivity
The recommendations on husbandry of salamanders are as complex as the life histories of different
species. Salamanders live in almost all climatic conditions from polar tundra to tropical fully humid forests
and have arboreal, terrestrial, fossorial (burrowing) and aquatic forms. Hence, depending on the species,
the husbandry approaches vary greatly. In general terms, the aquatic species are kept in aquariums,
whereas terrestrial species are normally kept in close facilities (terrariums) (Pasmans et al., 2014).
All salamanders are ectothermic, their body temperature is dependent on the environment;
therefore, temperature control is an important part of their husbandry. In general, salamanders live in
colder temperatures ranging from 15°C to 20°C, with the exception of tropical species. The facilities for
keeping salamanders have to be adapted to the thermal requirements of the kept species, and e.g. air
conditioned rooms or unheated underground rooms may be used. Water content in enclosures follows
the habitat of the given species, from damp conditions with occasional misting to classic aquaria. The
water quality has to be continuously maintained, as salamanders are sensitive to elevated ammonia
levels (Harvey Pough, 2007; Association of Zoos and Aquariums, 2012).
All salamander species and their larvae are carnivorous, preferring live prey. Food size depends on the
species and age, from minute crustaceans, springtails, fruit ﬂies up to small rodents, mice or ﬁsh. Some
aquatic species are fed with tadpoles or eggs of easily bred frogs. The food is usually bought in specialised
pet-shops, bred by the keepers or in some cases collected from the wild (Pasmans et al., 2014).
The size and construction of enclosures depend on the biological requirements, the keepers0
preferences and the purpose of keeping the salamanders, etc. The most common setting is use of glass
vivaria mimicking the habitat. For quarantine purposes ‘spartan enclosures’ with easily cleanable surfaces
and disposable substrate are used (Pasmans et al., 2014). Keepers and breeders of larger numbers of
individuals build outside artiﬁcial ponds and tanks, so the animals have natural climatic conditions. Such
settings have to be protected from predators (mammals, birds, snakes) and to avoid the possibility of
escape. Ponds and large tanks in general provide better conditions for keeping and breeding the
salamanders, but complicate the process of keeping track of the numbers and the health of the kept
animals (Harvey Pough, 2007; Association of Zoos and Aquariums, 2012; Pasmans et al., 2014).
Bsal in salamanders
www.efsa.europa.eu/efsajournal 39 EFSA Journal 2018;16(4):5259
3.3.2. Risk-mitigating measures and methods for protection of kept salamanders
(ToR 4a)
3.3.2.1. Screening of the kept populations
The owners of the salamander kept populations should test all the animals for Bsal (according to
the protocol reported in Section 3.1.2.1). After knowing the status of the salamanders, the new
obtained animals should be Bsal tested before introduction into the new collection. Bsal screenings of
captive populations have been reported for some EU MSs and in the USA (Sabino-Pinto et al., 2015;
Fitzpatrick et al., 2016; Klocke et al., 2017). The feasibility of this measure was scored from 4 to 5,
because the screening protocols are already well described and, due to the community of keepers, it is
possible to reach most of the kept populations (e.g. via social networks). In addition, the keepers have
strong motivations to have their salamanders tested. The expected effectiveness is between 2 and 5.
The high uncertainty reﬂects variation in the possible consequent actions (e.g. treatment or euthanasia
of the Bsal-positive collections), or incomplete reach of the existing kept populations.
3.3.2.2. Treatment of the positive cases
All animals that test Bsal-positive should be treated according to the protocol reported in
Section 3.2.1 before entering enclosures with the other animals. Based on infection dynamics, at least
3 weeks after treatment, animals should be retested for the presence of Bsal. During this period,
animals should be kept in quarantine. This is not purely a protection measure: it is an intervention
measure for the infected animals and a prevention measure for preventing spread in the remaining
population or introducing the pathogen into wild populations. The experts scored its feasibility from 4
to 5, because the treatment protocols are already well described and tested and easy to be
implemented. However, there is uncertainty about the suitability of the existing treatments for many
species (e.g. heat treatment). The effectiveness was scored from 4 to 5, because efﬁcacy has been
proven under laboratory conditions, but still several unknowns exist across the species. Both heat
treatment and antimicrobial treatment are highly effective for killing the fungus; while host species
may be negatively affected, the fungus is still removed.
3.3.2.3. Increase in owners’ awareness
The attitude of the stakeholders involved is a key measure for disease control success, and this
attitude is highly dependent on their education and the communication provided to them. Public
awareness of the potential introduction of Bsal or the signs/symptoms of infection could aid managers
in their responses. The stakeholders involved in keeping salamanders are mainly keepers (hobbyists),
breeders and stores.
Examples to increase awareness include disease information (how it spreads, which are the signs,
how it could be identiﬁed and treated, levels of mortality and morbidity, etc.) and also information on
good practices (i.e. on how to prevent the spread of the disease) for keepers and stores that can be
spread via the Internet, social media, advertisements, movies, ﬂyers or presentations at meetings/
conferences on a regular basis. It includes information papers in the stores for the customers. The
experts scored the feasibility of this measure as 5 because sharing information within the community
of salamander keepers/breeders and recommendations to minimise disease risks are well developed.
Effectiveness was scored between 3 and 4. Doubts on ability to effect sustained behavioural change
results in substantial uncertainty.
3.3.2.4. Development of good practices and hygiene protocols
The development of good practices manuals and written guidelines on hygiene protocols that would
support safer keeping and management of salamanders in captivity, of the equipment in which they
are in contact, and of the environment, is considered an important tool for the protection of kept
salamanders.
This measure could be applied to the keepers, breeders and stores/pet-shops.
For keepers/breeders and stores/pet-shops, the experts scored this measure similarly for feasibility
(5; few barriers to developing protocols to a high standard) and effectiveness (from 3 to 4).
Uncertainty exists about its effectiveness due to issues of compliance and effecting sustained
behavioural change.
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This measure includes willingness to participate in clean trade practices (absence of Bsal in kept
salamanders) and seeking veterinary health management of the kept salamanders (e.g. proper clinical
and necropsy procedures).
The manuals should also explain for example: (i) how to handle salamanders, (ii) how to clean and
disinfect (or dispose of) the equipment in contact with the animals, (iii) the correct use of water (e.g.
tap water), substrate (e.g. commercial) and soil, (iv) the correct disposal of the waste water and
substrate (see Section 3.2.4). Information should be given also on animal escape control, e.g. to have
equipment for outdoor and indoor housing for preventing the escape of salamanders and the entry of
other animals (e.g. birds, rodents). It is also important that the animals are not mixed. Upon
acquisition of one or more new animals, they should be Bsal tested and kept separately from the
others until the test results are available. The animals that are Bsal positive need to be treated (see
Section 3.2.1) and cannot be in contact with the other animals until they test Bsal negative.
Salamanders kept in captivity must not be released into the wild nor have direct or indirect contact
with the natural environment.
Registration of the facilities where salamanders are kept
This measure is considered relevant because it can give important information on the number of
salamanders in captivity, the main families that are kept and the location of the husbandry systems.
It can incorporate keepers, breeders and stores and it implies the presence of an ofﬁcial register
and the information may be used e.g. for Bsal outbreaks.
3.3.2.5. Registration of the keepers/breeders of salamanders
Registration of keepers’ and breeders’ facilities with an indication of at least: (i) where they are
located, (ii) the species that are kept (or if species level identiﬁcation is not possible then at least for
the main families kept), and (iii) the range of number of animals that are kept (e.g. 1–10; 10–100;
> 100).
As the feasibility of individual registration is inﬂuenced by several factors (e.g. the measure is in
principle well established but there could be potential reluctance to register if, for example, registration
is perceived to be a prescriptive/onerous duty or requirement), the experts scored the feasibility of this
measure with high variability, from 1 to 5. This was in contrast with the higher rated feasibility for
screening because experts considered that in that case there would be increased individual motivation
among keepers for testing their captive population. The effectiveness of registration was scored
between 1 and 4 because, although registration should imply recognition of good practice, registration
itself is not a measure protective to Bsal spread but rather needs to be combined with further actions.
Registration of the stores/pet-shops of salamanders
Register of the stores and pet-shops selling salamanders with indication of at least: (i) where they
are located, (ii) the main species that they sell (or if species level identiﬁcation is not possible then at
least at a family level), and (iii) the maximum number of salamanders that their facilities can keep.
The feasibility of registration of stores/pet-shops was highly evaluated (5), because they are
relatively easy to register or are even already registered by law in several MSs.
The effectiveness was scored between 1 and 4 because although registration should imply
recognition of good practice, registration itself is not a measure protective to Bsal spread, which needs
further actions. In addition, it has to be considered that other forms of salamander exchange exist
(see Section 3.2.3.2).
3.3.2.6. Education and training of stakeholders
Considering that it is important that good practices manuals and hygiene procedures are followed
by keepers, breeders and stores/pet-shops that deal with salamanders, this measure concerns the
organisation of ad hoc training courses on correct keeping and managing amphibians for salamanders’
stakeholders. The experts scored the feasibility of this measure from 3 to 4, because it is resource
demanding and recruiting stakeholders to attend is likely to be challenging. The effectiveness was
scored from 4 to 5 because, providing attendance, practical engagement should enhance good
practice.
Table 4 summarises the risk-mitigation measures identiﬁed to be relevant for protecting captive
salamanders in the places where they are kept, identiﬁes whether each measure is currently in place,
given the current knowledge, and reports the results of the experts’ opinion assessment on the
feasibility and effectiveness of each measure (for the details on the methodology and full description of
the results, see Section 2.2.4 and Appendix C (Section C.4)).
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Table 4: Risk-mitigation measures and methods for protection of kept salamanders and qualitative
assessment of their feasibility and effectiveness (*)
# Measures Deﬁnition/explanation In place (e.g.) Feasibility Effectiveness
1 Screening of the
kept populations
Test skin swabs from captive
kept salamanders for
presence of Bsal (see
Section 3.1.2.1)
Non-systematic
screening: BE
(research funding)
CZ (research funding)
DE (research funding)
NL (state funding)
UK (research funding)
4–5 2–5
2 Treatment of the
positive cases
Treatment of the Bsal-
positive salamanders (see
Section 3.2.1)
BE (private funding)
NL (research funding,
private funding)
DE (research funding,
private funding)
4–5 4–5
3 Increase in
owners’
awareness
Disease information and
information on good
practices for keepers,
breeders and stores via
multiple tools (e.g. Internet,
advertisements, oral
presentations at meetings,
socials)
BE, ES, FR, DE, IT, NL,
UK
5 3–4
4 Good practices
and hygiene
protocols for
keepers and
breeders
Develop good practices
manuals and written
guidelines with hygiene
protocols for correct
management of salamanders
in captivity, the equipment
they are in contact with and
the environment
For keepers and breeders of
salamanders
To a certain extent in:
BE, ES, FR, DE, IT, NL,
UK
5 3–4
5 Good practices
and hygiene
protocols for the
stores/pet-shops
As above, for the pet-shops
and stores selling
salamanders
No 5 3–4
6 Registration of the
keepers/breeders
of salamanders
Registration of keepers’ and
breeders’ facilities with an
indication of at least: (i)
where keepers are located,
(ii) the species that are kept
(at least for the main
families kept), and (iii) the
range of number of animals
that are kept (e.g. 1–10;
10–100; > 100)
No 1–5 1–4
7 Registration of the
stores/pet-shops
of salamanders
Registration of the stores
and pet-shops selling
salamanders with indication
of at least: (i) where they
are located, (ii) the main
species that they sell (at
least at a family level),
(iii) the max amount of
salamanders that their
facilities can keep
In some EU MSs
(e.g. IT)
5 1–4
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Figure 6 summarises the feasibility x effectiveness assessment of mitigation measures and methods
for protection of kept salamanders revealing their relation on a feasibility (x-axis) vs effectiveness (y-
axis) plane. No measure was considered certainly perfectly feasible and effective. ‘Treatment of the
Bsal positives’, as well as ‘good practice/hygiene protocols’ and ‘increase awareness activities’ were
measures considered promising on both scales. Other measures were attached with greater
uncertainty in either dimension, i.e. ‘screening of the kept salamanders’. Combinations of measures will
improve effectiveness; feasibility may not increase due to a combination of multiple efforts in
implementation.
3.3.3. Risk-mitigating measures and methods for on-site protection of wild
salamanders in their natural habitats (ToR 4b)
There are numerous potential measures and methods that, either alone or when combined, could
be considered risk-mitigation actions for the on-site protection of wild salamanders in natural habitats.
This section describes a suite of such actions, ranging from direct risk-reduction approaches (e.g.
implementing hygiene protocols, such as disinfection) or supporting actions that would increase
# Measures Deﬁnition/explanation In place (e.g.) Feasibility Effectiveness
8 Education and
training of
stakeholders
Organise training courses on
correct keeping and
managing amphibians for
keepers, breeders, stores,
pet-shops
No 3–4 4–5
(*): The feasibility was assessed on a continuous scale from ‘least feasible’ to ‘most feasible’ and the effectiveness was assessed
on a continuous scale from ‘negligible’ to ‘fully protective’. After consensus appraisal of the outcomes of the individual
judgements (see Appendix C, Section C.4.1) and discussion of particular reasoning, the overall outcome was represented by
an interval covered by the central estimates across all experts. The quintiles of value distribution of judgements were
converted into a scale from 1 to 5. The broader is the reported interval, the greater is the uncertainty comprised in the
judgements.
Figure 6: Overview of the consensus judgement and uncertainty for feasibility and effectiveness of
the mitigation measures assessed by experts for protection of kept salamanders. For exact
deﬁnition of feasibility and effectiveness used in the judgement and individual level
uncertainties, see Appendix C (Section C.4). The branch length in each dimension
represents the remaining variability in central expert judgement after consensus discussion
(see Table 4). The areas under the curves have no meaning
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feasibility or effectiveness of other actions (e.g. steps that would facilitate early detection of mortality
events, such as public awareness campaigns).
The Guidance on the hygiene procedures for the control of diseases in wild amphibian populations
(Murray et al., 2011a) was consulted to help set out the measures to address this ToR.
The measures reported below (from Sections 3.3.3.1 to 3.3.3.7) were identiﬁed by the experts as
the main issues for on-site protection of wild salamanders preventing Bsal introduction and/or spread
in their natural habitats. These measures have been assessed for their feasibility and effectiveness
(see Table 5).
Phillott et al. (2010) recommended that ﬁeld researchers evaluate their activities to determine the
relative risk of pathogen transmission and spread compared with background levels (i.e. the risk posed
by other mechanisms of disease transmission or pathogen dispersal) and implement appropriate
strategies to minimise this risk during ﬁeld studies. The risk of transmission and spread should also be
evaluated by researchers, animal ethics committees and government agencies issuing permits and for
all other stakeholders working with wild amphibians (e.g. environmental consultants).
Individuals studying amphibians often travel and collect samples of animals from multiple sites. It is
important to recognise that humans may aid in the transmission (passing of disease from an infected
to an uninfected individual), and spread (movement of disease geographically) of diseases. The risk of
disease transmission and spread may be increased due to movement of amphibians or personnel
(between isolated areas of habitats or between captive husbandry and laboratory facilities) and by the
handling of amphibians.
3.3.3.1. Site deﬁnition and visitation
Before commencement of any ﬁeld work, ﬁeld sites should be deﬁned robustly to identify potential
risks for the spread of disease between sites (see Section 3.1.2.2). The deﬁnition of the boundary of a
site may not be straightforward and may depend on a number of factors, including habitat
characteristics, natural barriers to dispersal and population/meta-population characteristics (see Murray
et al., 2011a, for further guidance).
Successively, a strategy for visiting sites should be deﬁned taking into account that multiple sites
might be visited in sequence and infection status may differ between sites. In principle, visiting
infected sites after uninfected sites should reduce risk of disease spread.
The feasibility of both measures (‘site deﬁnition’ and ‘site visitation strategy’) was scored by the
experts to be 5 for adequately trained/knowledgeable biologists. Experts suggested that for other ﬁeld
workers feasibility might be lower, requiring further training about site deﬁnition relevant to wildlife
disease.
The effectiveness of ‘site deﬁnition’ was scored from 2 to 3 because it is not a protection measure
per se but it must rather be considered as a component of a coherent, multi-action strategy.
The effectiveness of ‘site visitation strategy’ was rated from 3 to 4. As for the previous measure,
deﬁning a site visitation strategy was considered to be of most value as part of a coherent, multi-
action strategy, but it was scored to be somewhat more effective than the ‘site deﬁnition’ measure for
the prevention of Bsal spread as it represents a direct risk-reduction measure. Experts noted that the
feasibility of this measure would be low or not applicable if Bsal status of individual sites is unknown.
3.3.3.2. Hygiene procedures
Cleaning and disinfection of ﬁeld worker body parts and equipment
Before a site is entered and/or after ﬁnishing work at a site, exposed body parts (e.g. hands, arms,
knees), clothes and footwear and equipment should be cleaned and disinfected (see Section 3.2.1 for
disinfection protocols and Murray et al., 2011a for additional practical details).
Both measures on cleaning and disinfection activities were rated as highly feasible (‘cleaning and
disinfection of ﬁeld worker body parts’ = 5, ‘cleaning and disinfection of ﬁeld equipment’ = from 4 to 5)
as the guidelines are already used in practice. Uncertainty relates to the practicality of disinfecting
large equipment (e.g. vehicles).
Effectiveness was rated from 3 to 4, for ‘cleaning and disinfection of ﬁeld worker body parts’ and
from 4 to 5, for ‘clean and disinfection of ﬁeld equipment’. For equipment, more aggressive
disinfectants can be used, which was considered likely to raise efﬁcacy. Uncertainty was related to
people’s willingness to comply with existing guidelines and whether the measures could be consistently
performed correctly.
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Hygiene procedure and good practices for the movement and handling of wild salamanders
When handling is essential, care must be taken to ensure individuals do not have their exposure to
pathogens elevated over background exposure levels.
When possible and practical, disposable items (e.g. single-use latex, nitrile or vinyl gloves, single-
use plastic bags, containers) should be used when handling amphibians.
In situations in which gloves are not available or suitable: hand washing with 70% ethanol
(allowing hands to dry) between handling individual animals is acceptable (although repeated use on
the human skin is not recommended, and because alcohol is toxic to amphibians hands must be
washed thoroughly in water after treatment with alcohol). If 70% ethanol is not available, the
minimum treatment is hand washing in the water to which the amphibian is normally exposed before
and after handling.
In situations in which amphibians must be held temporarily, individuals should be housed in single-
use containers (e.g. plastic bags) or in containers disinfected (see above and Section 3.2.1) between
each animal, and adults should not be held in groups.
The feasibility of all these four measures (‘use of disposable items’, ‘care in handling’, ‘hands
disinfection’, and ‘single use of containers’) was rated 5, as they are easy to implement and existing
protocols for minimising disease risks in amphibians could be easily adapted or applied for Bsal. In
addition, handling is generally carried out by experienced people who likely already have some
knowledge/training relevant to amphibian diseases or have completed permit applications that should
include such considerations.
Effectiveness ratings varied from 2 to 5 (‘use of disposable items’ and ‘single use of containers’:
from 3 to 4; ‘care in handling’: from 3 to 5; ‘hands disinfection’: from 2 to 4). Uncertainty related to
people’s willingness to comply, whether the measures could be consistently performed correctly, and
the extent to which these measures are likely to inﬂuence disease transmission within infected sites
(i.e. anthropogenic vs natural processes).
Integrated hygiene approach
This measure consists in an integrated approach to prevent or limit disease transmission/spread in
wild or wild caught amphibians and it includes the hygiene practices (listed above). Feasibility was
scored from 4 to 5, slightly lower than most of the individual measures, as an integrated approach was
considered more difﬁcult to implement correctly due to the larger number of steps involved and
because some of the feasibility issues of the individual steps remain. However, effectiveness was
scored from 4 to 5, higher than most single measures, as a combination of measures is likely to
increase the overall effectiveness.
3.3.3.3. Capture and translocation of wild salamanders
Capture, handling and housing of wild salamanders should be minimised or avoided when possible.
Translocated amphibians should be treated as if they are infected and should not be transported
anywhere for release to the wild. If wild amphibians and their larvae must be housed for some time in
a captive situation (e.g. in laboratory, zoo or captive breeding facility), they should not be returned to
the wild. This group of measures also includes increasing awareness of practitioners who may capture
or translocate salamanders in the wild.
Feasibility of ‘avoid capture and handling of salamanders’ was scored from 4 to 5 because: it is
straight forward to deﬁne and this requirement could be reinforced through permit approvals.
Effectiveness was scored widely from 1 to 5. Uncertainty for effectiveness related to compliance issues
and also awareness of the researchers and other people authorised to work in the ﬁeld. In addition,
there are no procedures currently in place to provide guidance on re-housing or disposing of captured
amphibians within the EU.
Both feasibility and effectiveness of ‘prevent translocation of wild animals’ were scored from 4 to 5,
because this measure should be straight forward to deﬁne and requirement could be reinforced
through permit approvals. Uncertainty in the feasibility was due to the possibility that different ﬁeld
researchers may have different study purposes/priorities (e.g. environmental consultants vs academic
research/conservation priorities vs disease-speciﬁc priorities).
The experts assessed both feasibility and effectiveness of ‘prevent return of the captive animals to
wild’ as 5; again because this measure is a simple requirement to impose on anyone with a permit to
take wild amphibians into captive situations and because it has the potential to completely remove the
risk of Bsal spread. Uncertainty for effectiveness was again related to compliance issues.
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3.3.3.4. Increase public awareness and participation
The attitude towards risk-reducing practices of stakeholders involved in amphibian-related activities
is a key measure for disease control success, and this attitude is highly dependent on the level of
education and awareness and the ability to spread good information via communication tools. Public
awareness of the potential introduction of Bsal or the signs/symptoms of infection could aid managers
in their responses.
Communication between the general public and government agencies responsible for wildlife
disease management can facilitate the early detection of invading pathogens (Langwig et al., 2015).
Examples to increase awareness include education campaigns to promote participation and enforce
hygiene standards (see Sections 3.3.2.3 and 3.3.2.4), installation of signage for people visiting natural
areas (e.g. forests, parks), and producing informational ﬂyers. It also includes facilitating reporting of
signs/symptoms of certain issues (e.g. sightings of invasive species), and for disease related issues,
providing a means to communicate observations of sick or dead animals (e.g. via creation of hot-lines).
The experts scored the feasibility of this measure from 4 to 5 because stakeholders are reasonably
easy to reach (e.g. via the Internet, signage); however, effectiveness was rated between 3 and 4
because this preventative measure is only based on information dissemination, perceived to have a
potentially limited capacity to effect sustained behavioural change. This limitation is also reﬂected by
the uncertainty.
3.3.3.5. Passive surveillance
A reserve capacity of diverse and ﬂexible teams is needed to address wildlife disease outbreaks
should biosecurity measures fail and a disease is introduced (Berger et al., 2016). Bsal-passive
surveillance involves the collection of dead salamanders, which should then be sent for disease
diagnosis. Wildlife disease emergency teams should be set up for passive surveillance, as contact
points for reporting and consultation if a dead salamander is found. The role of the contact point is to
make sure that the reported animal is investigated for Bsal and discount it if it is not relevant. The
emergency team includes a reference laboratory where testing dead salamanders for Bsal can be
conducted, reporting the Bsal-positive animals and accompanying relevant information (e.g. the site
where the Bsal-positive dead salamander has been found) to the local authorities (see also
Section 3.1.2.2).
The feasibility of ‘collect and send dead amphibians for Bsal diagnosis’ was scored from 4 to 5
because guidelines on submission of dead animals already exist for its implementation. The experts
scored the effectiveness of this measure from 3 to 4 because, if implemented, it supports early
detection but it is not itself a risk-mitigation measure, although it was agreed that information on Bsal
detection could subsequently lead to further targeted risk-reducing measures.
The feasibility of ‘set up wildlife disease emergency teams for passive surveillance’ was scored from
4 to 5. Uncertainty related to the implementation of this measure in local situations in which
monitoring is not yet in place. The effectiveness of this measure was scored as 4 because it depends
on submission activities and, as above, subsequent actions available to further mitigate risks.
3.3.3.6. Wild population monitoring
Enhancing the collation and retrieval of data on salamander population sizes, distributions and
trends is considered important for conservation management. In situ management activities should
strive to be working with the best available data on population sizes and conservation status.
Population monitoring from clearly deﬁned and harmonised surveys can help provide such information.
However, to date, the collection of data on salamanders in the EU is fragmented.
The experts judged the feasibility of this measure as 4. Some uncertainty relates to resource
demands for amphibian population monitoring. Effectiveness was scored from 3 to 4, because this
measure is not a risk-mitigation measure to prevent the spread of Bsal per se, but rather a supportive
measure that can help improve the feasibility and effectiveness of other measures.
3.3.3.7. Active surveillance
Active surveillance is the proactive collection of data on Bsal presence in amphibian populations to
promote early detection for disease introduction. This form of surveillance involves visiting
subpopulations of salamanders and screening for disease according to a clearly deﬁned and
harmonised sampling strategy, with the aim of being able to robustly discriminate disease presence
from absence. Developing a robust strategy requires information from a range of domains, from
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characteristics of the population being sampled (e.g. host population size and distribution) to
diagnostic test properties. For Bsal, much of information that is likely required to develop an effective
active surveillance strategy is considered limited (see Section 3.1.2.2). Feasibility was so scored from 2
to 4, with the degree of uncertainty related primarily to the resource demands. Effectiveness was
scored as 4 because it depends on the quality of the sampling strategy put in place as well as
subsequent actions available to further mitigate risks should Bsal be detected.
Table 5 summarises the risk-mitigation measures for on-site protection of wild salamanders in their
natural habitats identiﬁed to be relevant to responding to the threat of Bsal in the EU, identiﬁes
whether each measure is currently in place, given the current knowledge, and reports the results of
the experts’ opinion solicitation on the feasibility and effectiveness of each measure (for details on the
methodology and full description of the results, see Section 2.2.4 and Appendix C (Section C.5)).
Table 5: Risk-mitigation measures and methods for on-site protection of wild salamanders in their
natural habitats and relevant qualitative assessment of feasibility and effectiveness(*)
# Measures Deﬁnition/explanation
In place
(e.g.)
Feasibility Effectiveness
1 Site deﬁnition Deﬁning a site robustly to identify opportunities
for disease spread between sites
No 5 2–3
2 Site visitation
strategy
Deﬁning a site visitation strategy when
attending multiple sites in sequence
No 5 3–4
3 Cleaning and
disinfection of
ﬁeld worker
body parts
Cleaning and washing or wiping with a suitable
disinfectant (see Section 3.2.1) of hands, arms,
knees, etc. before a site is entered and/or after
ﬁnishing work at a site
Flanders
(BE)
5 3–4
4 Cleaning and
disinfection of
ﬁeld equipment
Cleaning and disinfection of footwear and
equipment (e.g. vehicles, nets, balances) at the
commencement of ﬁeldwork and between each
sampling site
Flanders
(BE)
4–5 4–5
5 Use disposable
items
Use of disposable items (e.g. single-use latex,
nitrile or vinyl gloves) for moving and handling
salamanders
Flanders
(BE)
5 3–4
6 Care in handling
salamanders
If handling is essential, ensure that individuals
do not have their exposure to pathogens
elevated over their background exposure levels
Flanders
(BE)
5 3–5
7 Hands
disinfection
If gloves for handling animals are unavailable,
disinfect hands with 70% ethanol and wash
hands thoroughly in water after treatment. If
ethanol is not available, the minimum treatment
is hand washing in the water to which the
amphibian is normally exposed
Flanders
(BE)
5 2–4
8 Single use of
containers for
temporarily
holding
salamanders
For temporarily held animals, ensure single-use
or disinfected containers between each animal.
Adults should not be held in groups
No 5 3–5
9 Integrated
hygiene
approach
An integrated approach to prevent or limit
disease transmission includes all the single
measures on hygiene procedures and good
practices outlined above
Flanders
(BE)
4–5 4–5
10 Avoid wild
salamanders
capture and
handling
Avoiding or minimising the capture, handling
and housing of wild salamanders helps reduce
or remove anthropogenic sources of disease
transmission between animals and introduction/
spread from one place to another
Flanders
(BE)
4–5 1–5
11 Prevent
translocation of
wild animals
Treating translocated amphibians as if they are
infected can help mitigate the risk of intentional
translocation and therefore disease spread
Flanders
(BE)
4–5 4–5
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Figure 7 summarises the feasibility x effectiveness assessment of risk-mitigation measures and
methods for on-site protection of wild salamanders in their natural habitats revealing their relation on
a feasibility (x-axis) vs effectiveness (y-axis) plane. Colour coding follows the logical structure of the
section above (e.g. green used for all hygiene-related measures). One measure was considered certain
perfectly feasible and effective being the ‘prevention of return to the wild after temporary captivity’.
‘Disease emergency teams’, ‘prevent translocation of wild animals’, ‘integrated hygiene approach’ and
‘cleaning/disinfection of equipment’ were considered promising on both scales. Combinations of
measures will improve effectiveness; feasibility may not increase due to the combination of multiple
efforts in implementation (e.g. compare ‘integrated hygiene approach’, i.e. the combination, to single
hygiene measures all with perfect feasibility but limitations in effectiveness).
# Measures Deﬁnition/explanation
In place
(e.g.)
Feasibility Effectiveness
12 Prevent return of
captive animals
to the wild
Wild amphibians and their larvae that need to
be housed for some time in a captive situation
(e.g. laboratory, zoo or captive breeding
facilities) should not be returned to the wild.
The measure includes increasing awareness of
salamanders’ keepers that should not release
kept salamanders into the wild
No 5 5
13 Increase public
awareness and
participation
Disease information and education campaigns
to promote participation and enforce hygiene
protocols and good practices via multiple tools
(e.g. installation of signage for people visiting
natural areas and producing informational
ﬂyers). It includes facilitating reporting of signs/
symptoms (e.g. sighting for invasive species)
and means to communicate observations of sick
or dead animals (e.g. via creation of hot-lines)
AU, BE,
FR, DE, IT,
ES, NL, UK
4–5 3–4
14 Collect and send
dead animals for
Bsal diagnosis
As a part of passive surveillance, dead
amphibians should be collected and sent for
disease diagnosis
Flanders
(BE)
4–5 3–4
15 Set up wildlife
disease
emergency
teams for
passive
surveillance
A contact for reporting and consultation in the
case a dead salamander is found. This measure
includes a laboratory where testing salamanders
for Bsal (see Section 3.1.2.1), reporting the
Bsal-positive animals and accompanying
relevant information to the local authorities can
be conducted (see Section 3.1.2.2)
BE, FR,
DE, IT, ES,
NL, UK
4–5 4–5
16 Wild population
monitoring
To collate and retrieve data on population sizes,
distributions and trends
In some
MSs (see
Section
2.1.2),
however
no
database
is available
4 3–4
17 Active
surveillance
To actively collect data on Bsal presence in
amphibian populations by visiting and screening
for disease local populations of salamanders
according to a clearly deﬁned and harmonised
sampling strategy (see Sections 3.1.2.1 and
3.1.2.2)
In some
extend, in
some MSs
(see
Sections
2.2.2.2
and
3.1.1.3)
2–4 4
(*): The feasibility was assessed on a continuous scale from ‘least feasible’ to ‘most feasible’ and the effectiveness was assessed on
a continuous scale from ‘negligible’ to ‘fully protective’. After consensus appraisal of the outcomes of the individual judgements
(see Appendix C, Section C.5.1) and discussion of particular reasoning, the overall outcome was represented by an interval
covered by the central estimates across all experts. The quintiles of value distribution of judgements were converted into a
scale from 1 to 5. The broader is the reported interval, the greater the uncertainty comprised in the judgements.
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3.3.3.8. Other aspects to be taken into account when considering protection of
salamanders in their natural habitats
Most of the measures described above relate to disease risk-reducing activities related to
introduction and further spread of disease, especially those for which some evidence of reasonable
feasibility and/or efﬁcacy is already known or there has been proof-of-concept.
However, there are additional measures that although not currently considered feasible/effective
could become so in the future given additional investigation or in some cases if a major scientiﬁc
breakthrough is achieved. There are also some measures that have been trialled for Bd in the wild and
have exhibited some promise but only in very speciﬁc circumstances (in situ treatment, site
disinfection; Bosch et al. 2015; Hardy et al., 2015; Hudson et al., 2016; Drawert et al., 2017).
Most measures considered for eradication of Bsal from the wild after it has become established
(e.g. on-site treatment, site disinfection) fall into this group of measures, as do measures that may
fundamentally alter the host–pathogen relationship in favour of host survival (vaccination, probiotic
treatments).
Other measures could also conceivably slow or restrict the natural spread of Bsal from known
infected sites but have not been ﬁeld tested (e.g. barrier fencing, culling, habitat manipulation).
Other measures still are focused on stewarding threatened species through disease epidemics until
longer term solutions are proven or discovered (e.g. setting up captive backup populations, selective
breeding and population supplementation).
The measures listed in this section have not been assessed by the experts given their limited
relevance to responding to the present threat of Bsal introduction and/or spread in the EU.
3.3.3.9. Integrated infection management
The decision process for setting up mitigation strategies requires integrated thinking that assesses
mitigation options critically and embeds them within more comprehensive strategies for the conservation
of amphibian populations, communities and ecosystems (Garner et al., 2016). Provided proper infection
and population monitoring is implemented, combining several mitigation tools in so-called integrated
strategies is likely to increase the effectiveness of infection management. Integrated strategies are also
Figure 7: Summary of the consensus judgement and uncertainty for feasibility and effectiveness of
the mitigation measures assessed by experts for on-site protection of wild salamanders. For
exact deﬁnition of feasibility and effectiveness used in the judgement and individual level
uncertainties see Appendix C (Section C.5). The branch length in each dimension
represents the remaining variability in central expert judgement after consensus discussion
(see Table 5). The areas under the curves have no meaning
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preferred as no single measure is universally applicable. Hence, the capacity to combine several tools is a
factor modulating infection management success. However, the success of infection management in
wildlife also depends on several other factors: (a) the single or multihost nature and other characteristics
of the pathogen, (b) the availability of suitable diagnostic tools, (c) the characteristics of the wildlife host
(s), (d) the geographical range of the pathogen/reservoir (improved control in isolated versus continuous
populations) and the scale of the intervention effort (large-scale longitudinal programmes are better),
and (e) the attitude of the stakeholders involved (Gortazar et al., 2015).
It has also been postulated that transnational responses to infectious disease often come ‘too little,
too late’ to prevent the entry and spread of highly lethal fungal pathogens (Fisher et al., 2016).
Hopefully, the tools reviewed above, and in particular their combined use in integrated strategies, will
contribute to mitigate the potential risks of Bsal for salamander conservation in Europe.
4. Conclusions
1) Bsal surveillance is currently limited: active surveillance in wild salamanders is ad hoc in
Austria, Belgium, Croatia, the Czech Republic, France, Germany, Portugal, Slovenia, Spain,
Switzerland, the Netherlands and the United Kingdom; passive surveillance in wild
salamanders via contact points/emergency teams is temporally in place in Belgium, France,
Germany, Spain, the Netherlands and the United Kingdom; and surveillance in captive
salamanders is ad hoc in Belgium, the Czech Republic, Germany, Spain, the Netherlands and
the United Kingdom.
2) Bsal has been detected in collections of captive salamanders in Belgium, Germany, Spain,
the Netherlands and the United Kingdom, and in wild populations in some regions of
Belgium, Germany and the Netherlands.
3) The absence of detection (in particular in the wild) does not mean the absence of Bsal.
4) Data on salamander species distribution in the EU are available, meanwhile abundance data
are generally not comprehensive.
5) According to niche modelling, at least part of the range of distribution of every salamander
species in the EU overlaps with the climate conditions predicted to be suitable for Bsal.
6) The Bsal-speciﬁc qPCR has been shown to have a high speciﬁcity and sensitivity being a
reliable and feasible diagnostic tool.
7) Passive surveillance is considered the most suitable approach for detection of Bsal
emergence in wild host populations.
8) An active surveillance approach is likely to be both resource and data intensive. Some of the
key items to construct an active surveillance are: potential points of entry to the wildlife
habitat, species susceptibility, population sizes and knowledge of species distributions. Data
on these items are currently lacking.
9) Demonstration of Bsal absence in wild populations of salamanders is not currently
considered feasible.
10) It would be feasible to demonstrate absence of Bsal in a ‘closed population’ of a susceptible
salamander species kept in captivity by sufﬁciently long quarantine and absence of clinical
symptoms of Bsal conﬁrmed by visual observation. This should be complemented by testing
all animals at the end of a quarantine period.
ToR 2b: As regards presence, absence, surveillance and eradication, assess possible identiﬁcation of various
areas (e.g. countries, zones. territories) which may be considered infected with Bsal or free from it
ToR 2d: As regards presence, absence, surveillance and eradication, assess suitability of surveillance methods
to ensure reliable and robust demonstration of presence or absence of Bsal
ToR 3a–i: As regards spread of Bsal in and from infected areas or via infected animals or fomites, assess the
risk of survival, spread and establishment of Bsal within already infected areas and spread from infected areas
into other parts of the EU by natural movements of live salamanders taking into account especially relevant
geographical, hydrographical and meteorological conditions
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11) In the wild, Bsal can possibly be spread by both active carriers (e.g. salamanders, anurans)
and passive carriers (e.g. wild birds, water). Bsal is most likely maintained and/or spread in
infected areas by intra- and interspecies contacts of salamanders but potentially also by
interactions with anurans.
12) Bsal entry into new areas and populations is most likely to be caused by human activities
(mainly amphibian-related), but potentially also by wild birds and mammals and through
connected streams of water.
13) The risk-mitigation measures that were considered most feasible and effective for live
salamanders were either a ban or restrictions on salamander imports, hygiene procedures
and good practice manuals.
14) The feasibility and effectiveness of a ban or restriction on salamander import and trade
depend on the volumes of animals that are currently transported; these measures might
also boost illegal movements.
15) The effectiveness of heat treatment was considered high. However, the heat tolerance of
many salamander species is unknown.
16) Treatments with antimicrobials can be justiﬁed only for conﬁrmed Bsal-positive animals,
when not suitable for heat treatment.
17) For salamander products and by-products, heat-processing or desiccation is feasible and
effective to ensure safe international and intra-EU trade.
18) Combining several risk-mitigation measures (an integrated infection management strategy)
will improve overall effectiveness.
19) In populations of kept amphibians, Bsal spread can potentially occur via passive carriers
such as human movements and activities, waste water, equipment, substrate and fomites.
These risks can be mitigated by implementing hygiene procedures and good practices.
20) Bsal contamination of traded and/or kept salamanders via live silent carriers (wild birds and
anurans) is considered extremely unlikely as salamanders are normally kept indoors and
separated from anurans, if good practices are implemented.
21) The most feasible and effective risk-mitigation measures for protection of kept salamanders
from Bsal are the identiﬁcation and treatment of positive collections.
22) Mitigation measures for awareness, good practice and hygiene protocols are considered
feasible. Their effectiveness will increase by combining the available measures into an
integrated infection management strategy.
23) The most feasible and effective risk-mitigation measures for on-site protection of wild
salamanders from Bsal are: preventing release/return to the wild of kept or temporarily
housed wild salamanders and the translocation of wild amphibians.
24) Setting up contact points/emergency teams in support of passive surveillance is considered
feasible and effective.
ToR 3b: As regards spread of Bsal in and from infected areas or via infected animals or fomites, assess risk-
mitigating measures that could potentially be effective in ensuring safer international or intra-EU trade of live
salamanders (both captured in the wild and bred) and their products and by-products as regards the
transmission of Bsal including diagnosis and potential treatment(s)
ToR 4a: As regards protection from Bsal, assess the potential and feasible risk-mitigating measures and
methods in kept salamanders
ToR 3c: As regards spread of Bsal in and from infected areas or via infected animals or fomites, assess the
role of live silent carriers of Bsal in spreading it as vectors and those of fomites (e.g. waste water, animal by-
products. feed) and their risk-mitigating measures
ToR 4b: As regards on-site protection from Bsal, assess the risk-mitigating measures and methods for
salamanders in their natural habitats.
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25) Mitigation measures for hygiene procedures were considered feasible for anthropogenic
sources of risk, but less effective for natural mechanisms of spread (e.g. intra- or inter-
species transmission, potential carriers such as wild birds). Their effectiveness is likely
increased as part of an integrated approach.
5. Recommendations
1) Introduction of a harmonised system/protocol for Bsal detection throughout the EU is
desirable. Further research is needed to design an efﬁcient surveillance system that accounts
for the complexities of additional introduction or spread of Bsal in the EU (e.g. on potential
points of entry to the wildlife habitat, species susceptibility to natural infection, population
sizes and knowledge of species distributions), and to enable a risk analysis per species.
2) Data acquisition on abundance and distribution of salamanders across EU is needed for
future risk assessments, surveillance and eventual intervention; such new information would
also improve niche modelling for infection of Bsal.
3) Passive surveillance activities for Bsal would be enhanced with the implementation of
contact points/emergency teams in charge of all aspects of samples collection and
management and coordinating laboratory testing and information ﬂow.
4) Increasing awareness among professionals and the public of the role of enhanced passive
surveillance is recommended to improve early detection.
5) Movements of captive animals should be conditional on known health status for Bsal (Bsal
test negative).
6) The testing of quarantined animals should be performed as close as possible to the end of
the quarantine with qPCR (maximum in the last week).
7) Further studies are needed on thermotolerance treatments for Bsal as well as infection
susceptibility of amphibians (potential hosts, carriers, vectors).
8) Information about submitting samples for diagnostic, treatments, hygiene protocols and
good practices on Bsal should be provided to salamander keepers.
9) Guidelines on hygiene procedures and best practices need to be distributed to all relevant
stakeholders and could become integral components of permits for dealing with wild
salamanders (site visitation, capture, handling and movement).
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Glossary
Animal by-products not meant for human consumption
Animal products meant for human consumption
Bsal-susceptible species species that can become infected by Bsal and show clinical signs
and disease (with different levels of gravity up to death)
Bsal carrier any means of spread (biotic and abiotic) of Bsal potentially
resulting in transmission to the host. Active carriers are hosts
acting as biological vectors for the spores, whereas passive carriers
are mechanical vectors to which the spores can be attached.
A Bsal carrier that cannot be identiﬁed is a silent carrier
Bsal-resistant species species that do not become infected by Bsal
Bsal-tolerant species species that can become infected by Bsal in the absence of clinical
signs and pathology
Close population population of kept salamanders that has no exchange with others
(no immigrations no emigrations). In the context of this opinion,
a ‘close population’ would imply also appropriate implementation
of hygiene procedures and good practices
Disease spread movement of disease geographically
Disease transmission passing of disease from an infected to an uninfected individual
Meta-populations of salamanders populations of salamanders separated by space but connected by
dispersal of individual salamanders
Newts representatives of one group within the family Salamandridae
(subfamily Pleurodelinae). For taxonomic consistency, the use in
this scientiﬁc opinion of the term ‘salamanders’ is inclusive of ‘newts’
On-site protection protection that conventionally refers to wild animals in their natural
habitats
Subpopulation of salamanders group of salamanders that can contact each other. It is equal to
‘local population’ and ‘population on a site’
Synonym in taxonomy, is a system of accepted alternative names for species
Abbreviations
AHAW Animal Health and Welfare
AHL Animal Health Law
AU Austria
Bd Batrachochytrium dendrobatidis
BE Belgium
Bsal Batrachochytrium salamandrivorans
CI conﬁdence interval
CITES Convention on International Trade in Endangered Species
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CL conﬁdence level
CZ Czech Republic
ddPCR droplet digital PCR
DE Germany
ELS Extensive Literature Search
ES Spain
FR France
GE Genomic Equivalent
IATA International Air Transport Association
IR Ireland
IT Italy
IUCN International Union for Conservation of Nature
LAR Live Animal Regulations
MS Member State
NCA CR National Conservation Agency in Czech Republic
NGO Non-Governmental Organisation
NL the Netherlands
OIE The World Organisation for Animal Health
PCR Polymerase Chain Reaction
qPCR Real-time Polymerase Chain Reaction
RAVON Reptile, Amphibian and Fish Conservation the Netherlands
sp. Species
syn. Synonym
ToRs Terms of Reference
USA United States of America
UK United Kingdom
WG Working group
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Appendix A – Extensive literature search
A.1. Sources of information included in the search
Search strategies were undertaken to identify scientiﬁc literature on Batrachochytrium
salamandrivorans. The following resources were searched to identify relevant studies:
A) Bibliographic databases
1) Web of Science (http://www.webofknowledge.com), encompassing the following databases
(inception – 16 October 2017):
 Web of ScienceTM Core Collection
 BIOSIS Citation Index
 CABI: CAB Abstracts®
 Chinese Science Citation DatabaseSM
 Current Contents Connect®
 Data Citation IndexSM
 FSTA® – the food science resource
 KCI-Korean Journal Database
 Russian Science Citation Index
 MEDLINE®
 SciELO Citation Index
 Zoological Record®
2) Scopus (https://www.scopus.com) (inception – 16 October 2017)
3) PubMed (https://www.ncbi.nlm.nih.gov/pubmed) (inception – 16 October 2017)
B) Search engines
1) Invasive Species Compendium (http://www.cabi.org/isc/)
2) Google Scholar: to facilitate the treatment of the results, Google Scholar were be searched via
Publish and Perish (http://www.harzing.com/resources/publish-or-perish)
3) OpenAIRE (https://www.openaire.eu/)
4) WorldWideScience (http://www.worldwidescience.org): limited to papers and public access.
A.2. Sources of information included in the search
The search strings were designed to retrieve relevant documents to ‘Batrachochytrium
salamandrivorans’. The genus name, Batrachochytrium, was not included as an independent term in the
search strings in an attempt to maximise the precision of the searches, since it will retrieve publications
on ‘Batrachochytrium dendrobatidis’ that are non-relevant for this scientiﬁc opinion.
1) Web of Science (all databases)
Date of the search 16 October 2017
Set Query Results
#1 TS=(((Bsal OR Bs) AND (Urodela* OR salamand* OR Newt$ OR amphibia*)) OR
salamandrivorans)
Time span=All years
Search language=Auto
124
After de-duplication with the 2016 searches results: 37; after removing record from 1948: 36.
2) Scopus
Date of the search 16 October 2017
Set Query Results
#1 TITLE-ABS-KEY (((bsal OR bs) AND (urodela* OR salamand* OR newt$ OR amphibia*))
OR salamandrivorans)
47
After de-duplication with the 2016 searches results: 15; after removing record from 1979: 14.
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3) PubMed
Date of the search 16 October 2017
Set Query Results
#1 Search ((((“Urodela”[Mesh] OR urodela*[tiab] OR salamandr*[tiab] OR salamander*[tiab]
OR newt[tiab] OR newts[tiab] OR amphibia*[tiab]) AND (Bsal[tiab] OR Bs[tiab])))) OR
salamandrivorans[tiab]
29
After de-duplication with the 2016 searches results: 9.
A.2.1. Search strings used in search engines
1) Invasive Species Compendium. Advanced bibliographic search (http://www.cabi.org/isc/)
Date of the search 16 October 2017
Query Results
In all ﬁelds: (((((Bsal OR Bs) AND (urodela* OR salamander* OR salamandr* OR newt* OR
amphibia*)))) OR (salamandrivorans))
10
After de-duplication with 2016 searches and within the resource: 2.
2) Google Scholar (via Publish and Perish)
Date of the search 26 October 2017
Query Results
All the words: Salamandrivorans 450
After de-duplication with 2016 searches and within the resource: 235.
3) OpenAIRE (https://www.openaire.eu/)
Date of the search 26 October 2017
Query Results
Salamandrivorans 27
After de-duplication with 2016 searches and within the resource: 6.
4) WorldWideScience (http://www.worldwidescience.org)28
Date of the search 26 October 2017
Query Results
Salamandrivorans
Limited to papers and public access documents
270
After de-duplication with 2016 searches and within the resource: 30.
A.3. Reﬁnement of literature search results
The number of results retrieved from each information source was recorded. The output of the
searches, i.e. records retrieved from bibliographic databases and grey literature, was exported to
EndNote x8 together with the relevant metadata (e.g. title, authors, abstract).
In total, 957 records resulted from the initial searches and were exported to an EndNote library.
Duplicates among the 2016 ELS and records dated before 2013 were ﬁrst removed; the 332 resulting
records were compared and removed when two or more records were identical within the same
resource and/or across all resources (i.e. author/s, title, journal, pages, doi number). This yielded 250
records which were distributed in three EndNote libraries/Microsoft Excel ﬁles:
1) Bsal bibliographic database, including the results for Web of Science (all databases),
PubMed and Scopus and after de-duplication and removing of records dated before 2013:
41 records.
28 The results of WorldWideScience were limited to papers and public access documents.
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2) Bsal search engines, including the results for Google scholar OpenAIRE, WorldWideScience,
and Invasive Species Compendium and after de-duplication and removing of records dated
before 2013: 209 records.
Titles and abstracts were screened for relevance and to remove additional duplicates. The
screening was performed by two reviewers in parallel. Records were excluded if considered as
duplicates or not relevant and 47 records (43 papers and 4 supporting publications) were considered
pertinent after consensus reached by the two reviewers.
Screening of full-text publications, limited to publications in English, was carried out by ad hoc
experts when title and abstract did not allow assessing the relevance of a paper, and some of the
publications were not considered relevant (resulting in a ﬁnal number of 26 relevant papers and 4
supporting publications) or proving any additional value to address the question.
An overview of the numbers of the records that resulted from each step of the ELS is reported in
Tables A.1, and A.2 shows the list of relevant publications resulting from the ELS.
Table A.1: Overview of the number of results of the ELS
Initial
search
Database
Initial
count
Post de-duplication among the 2016
ELS results and removing of records
dated before 2013
16/10/2017 WoS (All databases) 124 36
16/10/2017 Scopus 47 14
16/10/2017 PubMed 29 9
16/10/2017 Invasive Species Compendium.
Advanced bibliographic search
10 2
26/10/2017 Google Scholar 450 234
26/10/2017 OpenAIRE 27 6
26/10/2017 WorldWideScience 270 30
Total 957 332
Number of records
After de-duplication within the same resource results and
among all the resources
250
After screening of titles and abstracts to identify additional
duplicates and relevant literature
43
After full texts screening, limited to English publications, to
identify relevant literature
26
Table A.2: List of relevant publications resulting from the ELS
ID Reference
1 Bachhausen (2017)
2 Dillon et al. (2017)
3 DiRenzo et al. (2017)
4 Drawert et al. (2017)
5 EFSA (2017)
6 Farrer et al. (2017)
7 Feldmeier et al. (2016)
8 Fisher et al. (2016)
9 Fisher (2017)
10 Garner et al. (2016)
11 Geiger et al. (2017)
12 Grant et al. (2017)
13 Hanlon et al. (2017)
14 Klocke et al. (2017)
15 Laking et al. (2017)
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ID Reference
16 Liew et al. (2017)
17 Nguyen et al. (2017)
18 Parrot et al. (2017)
19 Rohr et al. (2017)
20 Schmidt et al. (2017)
21 Speybroeck and Steenhoudt (2017)
22 Stegen et al. (2017)
23 Valenzuela-Sanchez et al. (2017)
24 Van Rooij et al. (2017)
25 Wang et al. (2017)
26 White et al. (2016)
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Appendix B – Details of the surveillance activities in place in the wild in
some European countries
Country
Region/
areas
Year Species tested
Number
of
animals
tested
Number
of
positive
animals
Number
of
negative
animals
Published/
acknowledged(*)
Austria Turnsee lake 2017 Ichthyosaura alpestris 13 13 (1)
Austria Vienna 2017 Salamandra
salamandra
187 187 (2)
Austria Carynthia 2017 Salamandra
salamandra
55 55 (2)
Austria Salzburg 2017 Salamandra
salamandra
7 54 (2)
Austria Tyrol 2017 Lissotriton vulgaris 2 2 (2)
Austria Tyrol 2017 Ichthyosaura alpestris 100 100 (2)
Austria Tyrol 2017 Salamandra
salamandra
43 43 (2)
Austria Tyrol 2017 Triturus cristatus 2 2 (2)
Austria Tyrol 2017 Salamandra atra 15 15 (2)
Austria Vorarlberg 2017 Salamandra atra 80 80 (2)
Belgium Liege 2013 Salamandra
salamandra
2 2 Spitzen-van der
Sluijs et al. (2016)
Belgium Vlaams
Brabant
2014 Salamandra
salamandra
1 1 (3)
Belgium Liege 2014 Salamandra
salamandra
35 35 Spitzen-van der
Sluijs et al. (2016)
Belgium Oost
Vlaanderen
2015 Salamandra
salamandra
210 210 Spitzen-van der
Sluijs et al. (2016)
Belgium Vlaams
Brabant
2015 Salamandra
salamandra
90 90 Spitzen-van der
Sluijs et al. (2016)
Belgium Antwerp 2015 Ichthyosaura alpestris 35 1 34 Spitzen-van der
Sluijs et al. (2016)
Belgium Oost
Vlaanderen
2016 Salamandra
salamandra
210 210 (3)
Belgium Vlaams
Brabant
2016 Salamandra
salamandra
90 90 (3)
Belgium Vlaams
Brabant
2017 Salamandra
salamandra
90 90 (3)
Belgium Oost
Vlaanderen
2017 Salamandra
salamandra
210 210 (3)
Croatia Dalmatia 2015 Proteus anguinus 14 14 (4)
Croatia Istria 2015 Proteus anguinus 4 4 (4)
Croatia Gorski Kotar 2015 Proteus anguinus 2 2 (4)
Croatia Zagreb 2016 Salamandra
salamandra
4 4 (4)
Czech
Republic
Prague 2015 Salamandra
salamandra
58 58 Balaz et al. (2018)
Czech
Republic
Central
Bohemian
2015 Salamandra
salamandra
38 38 Balaz et al. (2018)
Czech
Republic
Prague 2016 Lissotriton vulgaris 28 28 Balaz et al. (2018)
Czech
Republic
Prague 2016 Ichthyosaura alpestris 2 2 Balaz et al. (2018)
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Country
Region/
areas
Year Species tested
Number
of
animals
tested
Number
of
positive
animals
Number
of
negative
animals
Published/
acknowledged(*)
France Cevenne
(Cockle)
2015 Salamandra
salamandra
30 30 (5)
Germany Noordrijn
Westfalen
2014 Ichthyosaura alpestris 5 5 Spitzen-van der
Sluijs et al. (2016)
Germany Noordrijn
Westfalen
2014 Salamandra
salamandra
19 19 Spitzen-van der
Sluijs et al. (2016)
Germany Noordrijn
Westfalen
2014 Lissotriton vulgaris 19 19 Spitzen-van der
Sluijs et al. (2016)
Germany Saksen 2014 Lissotriton vulgaris 12 12 Spitzen-van der
Sluijs et al. (2016)
Germany Saksen 2014 Ichthyosaura alpestris 4 4 Spitzen-van der
Sluijs et al. (2016)
Germany Saksen 2014 Salamandra
salamandra
15 15 Spitzen-van der
Sluijs et al. (2016)
Germany Noordrijn
Westfalen
2015 Salamandra
salamandra
167 84 83 Spitzen-van der
Sluijs et al. (2016)
Germany Rijnland
palts
2015 Salamandra
salamandra
55 55 Spitzen-van der
Sluijs et al. (2016)
Germany Rijnland
palts
2015 Ichthyosaura alpestris 72 72 Spitzen-van der
Sluijs et al. (2016)
Germany Rijnland
palts
2015 Lissotriton helveticus 1 1 Spitzen-van der
Sluijs et al. (2016)
Germany Beieren 2015 Salamandra
salamandra
91 91 Spitzen-van der
Sluijs et al. (2016)
Germany Hessen 2015 Salamandra
salamandra
69 69 Spitzen-van der
Sluijs et al. (2016)
Germany Beieren 2015 Ichthyosaura alpestris 1 1 Spitzen-van der
Sluijs et al. (2016)
Germany Rijnland
palts
2015 Lissotriton vulgaris 15 15 Spitzen-van der
Sluijs et al. (2016)
Germany Nedersaksen 2015 Salamandra
salamandra
23 23 Spitzen-van der
Sluijs et al. (2016)
Germany Saksen-
anhalt
2015 Salamandra
salamandra
8 8 Spitzen-van der
Sluijs et al. (2016)
Germany Noordrijn
Westfalen
2015 Ichthyosaura alpestris 27 27 Spitzen-van der
Sluijs et al. (2016)
Germany Noordrijn
Westfalen
2015 Lissotriton vulgaris 117 117 Spitzen-van der
Sluijs et al. (2016)
Germany Noordrijn
Westfalen
2015 Triturus cristatus 27 27 Spitzen-van der
Sluijs et al. (2016)
Germany Th€uringen 2015 Triturus cristatus 23 23 Spitzen-van der
Sluijs et al. (2016)
Germany Baden
w€urttemberg
2015 Salamandra
salamandra
3 3 (5)
Portugal Elisabeth 2015 Lissotriton boscai 8 8 (5)
Portugal Varziela 2015 Chioglossa lusitanica 13 13 (5)
Portugal Barreiro 2015 Triturus marmoratus 4 4 (5)
Portugal Barreiro 2015 Lissotriton boscai 14 14 (5)
Portugal Gorbelas 2015 Salamandra
salamandra
1 1 (5)
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Country
Region/
areas
Year Species tested
Number
of
animals
tested
Number
of
positive
animals
Number
of
negative
animals
Published/
acknowledged(*)
Portugal Prados
Garcia Renda
2015 Lissotriton boscai 3 3 (5)
Portugal Prados
Garcia Renda
2015 Triturus marmoratus 2 2 (5)
Portugal Pena Rubia 2015 Triturus marmoratus 3 3 (5)
Portugal Fraga Escuro 2015 Lissotriton boscai 5 5 (5)
Portugal Castro
Laboreiro
2015 Lissotriton boscai 6 6 (5)
Portugal Castro
Laboreiro
2015 Triturus marmoratus 3 3 (5)
Portugal Rodeiro 2015 Lissotriton boscai 44 44 (5)
Portugal Rodeiro 2015 Triturus marmoratus 14 14 (5)
Portugal Lagoa da
Peneda
2015 Lissotriton boscai 23 23 (5)
Portugal Lagoa da
Peneda
2015 Triturus marmoratus 22 22 (5)
Portugal Podre 2015 Lissotriton boscai 12 12 (5)
Portugal Podre 2015 Triturus marmoratus 5 5 (5)
Portugal Curveira 01 2015 Lissotriton boscai 12 12 (5)
Portugal Bago De
Baixo
2015 Triturus marmoratus 20 20 (5)
Portugal Bago De
Baixo
2015 Lissotriton boscai 30 30 (5)
Portugal Varzea
Travessa
2015 Triturus marmoratus 33 33 (5)
Portugal Varzea
Travessa
2015 Lissotriton boscai 36 36 (5)
Portugal Pena Rubia 2015 Lissotriton boscai 12 12 (5)
Portugal Pena Rubia 2015 Triturus marmoratus 1 1 (5)
Portugal Castro
Laboreiro
2015 Lissotriton boscai 8 8 (5)
Portugal Castro
Laboreiro
2015 Triturus marmoratus 4 4 (5)
Portugal Dorna 2015 Lissotriton boscai 1 1 (5)
Portugal Dorna 2015 Triturus marmoratus 1 1 (5)
Portugal Portella 2015 Salamandra
salamandra
1 1 (5)
Slovenia Barje 2017 Triturus carnifex 1 1 (6)
Slovenia Barje 2017 Lissotriton vulgaris 2 2 (6)
Slovenia Ljubljana 2017 Rana dalmatina 1 1 (6)
Slovenia Ljubljana 2017 Rana temporaria 3 3 (6)
Slovenia Ljubljana 2017 Bufo bufo 4 4 (6)
Slovenia Ljubljana 2017 Salamandra
salamandra
1 1 (6)
Slovenia Barje (Bistra) 2017 Lissotriton vulgaris 1 1 (6)
Slovenia Kranj 2017 Proteus anguinus 2 2 (6)
Slovenia Ljubljana 2017 Xenopus laevis 2 2 (6)
Slovenia Litija 2017 Rana arvalis 3 3 (6)
Slovenia Mura 2017 Rana arvalis 7 7 (6)
Slovenia Smarje Sap 2017 Bufo bufo 1 1 (6)
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Country
Region/
areas
Year Species tested
Number
of
animals
tested
Number
of
positive
animals
Number
of
negative
animals
Published/
acknowledged(*)
Slovenia Ig 2017 Lissotriton vulgaris 1 1 (6)
Slovenia Ljubljana 2017 Triturus carnifex 3 3 (6)
Slovenia Vipava 2017 Proteus anguinus 3 3 (6)
Slovenia Ljubljana 2017 Proteus anguinus 5 5 (6)
Spain Picos de
Europa
National Park
2016 Ichthyosaura alpestris 82 82 (1)
Spain Sierra de
Guadarrama
National Park
2016 Ichthyosaura alpestris 27 27 (1)
Spain Alpedrete 2016 Triturus pygmaeus 13 13 (1)
Spain Pyrenees 2016 Calotriton asper 53 53 (1)
Spain Montseny
Natural Park
2016 Calotriton arnoldi 11 11 (1)
Spain Do~nana
National Park
2016 Lissotriton boscai 18 18 (1)
Spain Do~nana
National Park
2016 Pelobates cultripes 2 2 (1)
Spain Do~nana
National Park
2016 Pleurodeles waltl 7 7 (1)
Spain Do~nana
National Park
2016 Triturus pygmaeus 126 126 (1)
Spain Montseny
Natural Park
2017 Rana temporaria 2 2 (1)
Spain Montseny
Natural Park
2017 Bufo spinosus 4 4 (1)
Spain Montseny
Natural Park
2017 Calotriton arnoldi 32 32 (1)
Spain Montseny
Natural Park
2017 Triturus marmoratus 2 2 (1)
Spain Soncillo 2017 Salamandra
salamandra
5 5 (1)
Switzerland Lepontine
alps
2008–
2013
Ichthyosaura alpestris 10 10 Parrot et al. (2017)
Switzerland Lepontine
alps
2008–
2013
Salamandra
salamandra
2,223 2,223 Parrot et al.,(2017)
Switzerland Lepontine
alps
2008–
2013
Triturus carnifex 22 22 Parrot et al.,(2017)
Switzerland Lepontine
alps
2008–
2013
Lissotriton vulgaris 10 10 Parrot et al.,(2017)
Netherlands Limburg 2010 Salamandra
salamandra
6 6 Martel et al.,(2013)
Netherlands Limburg 2013 Ichthyosaura alpestris 1 1 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2013 Salamandra
salamandra
57 57 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2014 Ichthyosaura alpestris 49 1 48 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2014 Lissotriton vulgaris 12 12 Spitzen-van der
Sluijs et al. (2016)
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Country
Region/
areas
Year Species tested
Number
of
animals
tested
Number
of
positive
animals
Number
of
negative
animals
Published/
acknowledged(*)
Netherlands Limburg 2014 Lissotriton helveticus 24 24 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2014 Salamandra
salamandra
43 43 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2015 Ichthyosaura alpestris 225 37 188 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2015 Lissotriton vulgaris 76 65 11 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2015 Lissotriton helveticus 18 18 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2015 Salamandra
salamandra
32 32 Spitzen-van der
Sluijs et al. (2016)
Netherlands Gelderland 2015 Ichthyosaura alpestris 8 8 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2016 Salamandra
salamandra
2 2 Spitzen-van der
Sluijs et al. (2016)
Netherlands Limburg 2017 Ichthyosaura alpestris 97 97 Spitzen-van der
Sluijs et al. (2018)
Netherlands Limburg 2017 Salamandra
salamandra
35 35 Spitzen-van der
Sluijs et al. (2018)
Netherlands Limburg 2017 Lissotriton vulgaris 36 36 Spitzen-van der
Sluijs et al. (2018)
Netherlands Limburg 2017 Lissotriton helveticus 4 4 Spitzen-van der
Sluijs et al. (2018)
Netherlands Gelderland 2017 Triturus cristatus 2 2 Spitzen-van der
Sluijs et al. (2018)
Netherlands Noord
Holland
2017 Lissotriton vulgaris 8 8 Spitzen-van der
Sluijs et al. (2018)
Netherlands Gelderland 2017 Ichthyosaura alpestris 1 1 Spitzen-van der
Sluijs et al. (2018)
Netherlands Drenthe 2017 Triturus cristatus 1 1 Spitzen-van der
Sluijs et al. (2018)
Netherlands Zuid Holland 2017 Lissotriton vulgaris 8 8 Spitzen-van der
Sluijs et al. (2018)
Netherlands Noord
Holland
2017 Lissotriton vulgaris 1 1 Spitzen-van der
Sluijs et al. (2018)
(*): When the data are still unpublished, the data providers are cited and acknowledged:
(1): J. Bosch, C. Monsalve and C. Sausor, CSIC, Spain.
(2): F. Glaser, M. Grabher, P. Kaufmann, G. Ludwig, A. Maletzky, G. Munimanda, G. Pechlaner, D. Preininger, S. Smith, K. Smole-
Wiener, S. Schweiger, T. Wampula, C. Walzer and volunteers. Department of Integrative Biology and Evolution, University of
Veterinary Medicine Vienna and Sch€onbrunn Zoo, Austria.
(3): A. Martel, F. Pasmans, Ghent University, Belgium, research funded by ANB (Flemish government).
(4): M. Lukac, Faculty of Veterinary Medicine, University of Zagreb, Croatia.
(5): D. Schmeller, UFZ, Germany.
(6): R. Kostanjsek and N. Gunde Cimerman, Department of Biology, Biotechnical Faculty, University of Ljubljana, Slovenia.
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Appendix C – Individual experts’ assessments29
Expert knowledge was elicited in two steps ﬁrst asking for the central tendency and second for
range parameters of the uncertainty distribution according to the following protocol:
Please assess the following list of mitigation measures according to their
C.1. Part I – Judgement
Please ﬁrst assess the two measures on the scale between ‘rubbish’ (impractical, negligible) to
‘fantastic’ (easy-go, very high). The extreme categories are narratively described in the questionnaire.
During the judgement integrate across multiple aspects e.g. balancing cost issues, personal resource
needs and possible long-term sustainability. It is expected that you present your own expert view.
Please mark, e.g. by an ‘I’ where you want to set the mark.
Please now do the judgement across the table (preferably row by row). It is ok while judging to
compare with your other judgement outcomes. If you think you do not know the answer, please still
put a best guestimate (which you can later accompany with maximum uncertainty making your input
not inﬂuencing the outcome while keeping the uncertainty)
Example: o------------------------------i---------o
C.2. Part II – Uncertainty
After having marked your best guestimate judgement on the interval scale, you are asked to
associate each judgement with an uncertainty rating. The intention is to express the conﬁdence you
have post hoc into your rating. To carry out this, we will perform two steps on each judgement:
Step A: First, the most extreme implication of your uncertainty is provided by marking the minimal
and maximal value, right and left of your main judgement, for which you would think the feasibility/
effectiveness could be considered barely possible (even if you would be extremely astonished if it
actually would be that extreme). The ‘m’s should be placed left and right of – but not necessarily
symmetrically to – the main judgement.
Step B: Now please mark another two values e.g. ‘l’ (one left and one right of the main judgement
and in-between the two ‘m’s) that would indicate roughly the section of the interval in which you,
according to your uncertainty reﬂection, would expect the most adequate feasibility/effectiveness score
with at least 50% certainty – that’s the interval you would fairly expect to ﬁnd the adequate feasibility/
effectiveness score if you would, e.g. know more new facts addressing your uncertainty/knowledge
gaps. The two ‘l’s should be placed left and right of – but not necessarily symmetrically to – the main
judgement; and in-between the two ‘m’s.
Example: o-----m-----------------l---i-l--m--------o
Feasibility was assessed on a continuous scale from ‘least feasible’ to ‘most feasible’.
‘Least feasible’: implementation demanding extensive resources e.g. it requires lots of personnel
(qualiﬁed personnel handling most of the individuals), large amount of money (expensive for the
reagents and facilities; complexity of monitoring the conduct), danger to the environment (for other
species, e.g. causing toxicity or resistance).
‘Most feasible’: implementation demanding few resources for number of personnel (it does not
require additional qualiﬁed personnel), amount of money (cheap reagents and existing facilities/does
not require reagents and facilities) and implying negligible danger to the environment.
‘Effectiveness’ was assessed on a continuous scale from ‘negligible’ to ‘fully protective’.
‘Negligible’ for kept salamanders means that the activity does not alter the exposure to Bsal
introduction to uninfected populations or the further perpetuation between salamanders within an
infected population; for wild salamanders, it means that the activity does not alter the exposure to Bsal
introduction of an uninfected site or the further perpetuation between salamanders on an infected site.
‘Fully protective’: the activity leads to refractory protection of uninfected salamanders in a kept
population against Bsal infection, or to refractory protection of uninfected wild salamanders on a site
against Bsal infection (for on-site protection).
29 E1 to E3 are working actively with Bsal or Bd.
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C.3. Assessment of the feasibility and effectiveness of the risk-
mitigating measures for safer international or intra-EU trade of
salamanders (ToR 3b)
C.3.1. Individual assessment of the feasibility and effectiveness30
#
Risk-mitigation
measures
Deﬁnition/explanation
Score for feasibility
integrating human
resources, technical
efforts, treatment costs
and environmental
side-effects
Score for effectiveness in
preventing translocation of
pathogen along those
pathways the mitigation
measure is meant to
address
1 Preventative heat
treatment
To treat animals in an
environment at 25°C for
10 days (see
Section 3.2.1.2)
2 Quarantine Previously reported in
Grant et al. (2016)
Keep traded salamanders
in tanks at entrance point
for the whole Bsal
incubation time while
testing them for Bsal (see
Section 3.1.2.1) over the
last week
3 Require pre-
movement health
certiﬁcation
Previously reported in
Grant et al. (2016)
Individual Bsal test of
salamanders (see
Section 3.1.2.1)
4 Bsal testing at the
entry point
Keep traded salamanders
in tanks at entrance point
while individual testing for
Bsal (see Section 3.1.2.1).
Positive animals will be
treated (according to
protocols explained in
Section 3.2.1.1)
30 Expert knowledge is elicited using distributional parameters, i.e. most plausible as central tendency, barely possible values as
minimum and maximum (whiskers) and the central 50% interval of certainty (grey box). Data shown are before consensus
discussion.
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#
Risk-mitigation
measures
Deﬁnition/explanation
Score for feasibility
integrating human
resources, technical
efforts, treatment costs
and environmental
side-effects
Score for effectiveness in
preventing translocation of
pathogen along those
pathways the mitigation
measure is meant to
address
5 Restrict
importation of
some salamanders
Previously reported in
Grant et al. (2016)
Restrictions/partial ban of
salamander introduction
on the basis of the origin
or for some salamander
families
6 Ban all importation
of salamanders
Previously reported in
Grant et al. (2016)
Ban of all salamanders
trade (Martel et al., 2014;
Yap et al., 2015; Berger
et al., 2016; Richgels
et al., 2016)
7 Tracking all traded
species
Use an unique code for
identifying salamanders’
(or amphibians’ in general)
shipments (Auliya et al.,
2016; EFSA, 2017)
8 Hygiene
procedures
Equipment that enters in
contact with salamanders
should be cleaned and
disinfected (according to
the protocols reported in
Section 3.2.1) (EFSA,
2017)
9 Good practice
manuals
Draw up and spread a
good practice code
containing guidelines for
traders for handling
salamanders and fomites
(Murray et al., 2011b)
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#
Risk-mitigation
measures
Deﬁnition/explanation
Score for feasibility
integrating human
resources, technical
efforts, treatment costs
and environmental
side-effects
Score for effectiveness in
preventing translocation of
pathogen along those
pathways the mitigation
measure is meant to
address
10 Apply probiotics to
salamanders
Previously reported in
Grant et al. (2016)
Preventative probiotic in
salamanders’ skin. The
method has not been set
up for Bsal
Examples of studies on Bd
are reviewed in Bletz et al.
(2013)
11 Preventative heat
treatment
To treat animals in an
environment at 25°C for
10 days (see
Section 3.2.1.2)
C.4. Assessment of the feasibility and effectiveness of the potential
risk-mitigating measures for the protection of kept salamanders
(ToR 4a)
C.4.1. Individual assessment of the feasibility and effectiveness30
#
Risk-mitigation
measures
Deﬁnition/explanation in
place in the EU (e.g.)
Score for feasibility of
measures in KEPT
salamanders integrating
human resources,
stakeholder willingness
to comply/implement,
technical complexity,
feasibility of monitoring,
treatment costs and
long-term outlook, e.g.
permanent efforts
Score for
effectiveness in
protecting KEPT
salamanders
against Bsal
infection
1 Screening of the kept
populations
Test skin swabs from captive
kept salamanders for presence
of Bsal (see Section 3.1.2.1)
In place as non-systematic
screening:
BE (research funding)
CZ (research funding)
DE (research funding)
NL (state funding)
UK (research funding)
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#
Risk-mitigation
measures
Deﬁnition/explanation in
place in the EU (e.g.)
Score for feasibility of
measures in KEPT
salamanders integrating
human resources,
stakeholder willingness
to comply/implement,
technical complexity,
feasibility of monitoring,
treatment costs and
long-term outlook, e.g.
permanent efforts
Score for
effectiveness in
protecting KEPT
salamanders
against Bsal
infection
2 Treatment of the
positive cases
Treatment of the Bsal-positive
salamanders
(see Section 3.2.1)
In place:
BE (private funding)
DE (research funding, private
funding)
NL (research funding, private
funding)
3 Increase in owners’
awareness
Disease information and
information on good practices
for keepers, breeders and
stores via multiple tools (e.g.
Internet, advertisements, oral
presentations at meetings,
social media)
In place in:
BE, FR, DE, IT, ES, NL, UK
4 Good practices and
hygiene protocols for
keepers and breeders
Develop good practices
manuals and written
guidelines with hygiene
protocols for correct
management of salamanders
in captivity, the equipment
they are in contact with and
the environment
For keepers and breeders of
salamanders
In place in a certain extent in:
BE, FR, DE, IT, ES, NL, UK
5 Good practices and
hygiene protocols for
the stores/pet-shops
As above, for the pet-shops
and stores selling salamanders
Not in place yet
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#
Risk-mitigation
measures
Deﬁnition/explanation in
place in the EU (e.g.)
Score for feasibility of
measures in KEPT
salamanders integrating
human resources,
stakeholder willingness
to comply/implement,
technical complexity,
feasibility of monitoring,
treatment costs and
long-term outlook, e.g.
permanent efforts
Score for
effectiveness in
protecting KEPT
salamanders
against Bsal
infection
6 Registration of the
keepers/breeders of
salamanders
Registration of keepers’ and
breeders’ facilities with an
indication of at least: (i)
where keepers are located, (ii)
the species that are kept (at
least for the main families
kept), and (iii) the range of
number of animals that are
kept (e.g. 1–10; 10–100;
> 100)
Not in place yet
7 Registration of the
stores/pet-shops of
salamanders
Registration of the stores and
pet-shops selling salamanders
with indication of at least:
(i) where they are located,
(ii) the main species that they
sell (at least at a family level),
(iii) the maximum amount of
salamanders that their
facilities can keep
8 Education and
training of
stakeholders
Organise training courses on
correct keeping and managing
amphibians for keepers,
breeders, stores, pet-shops
Not in place yet
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C.5. Assessment of the feasibility and effectiveness of the potential
risk-mitigating measures for on-site protection of wild
salamanders in their natural habitats (ToR 4b)
C.5.1. Individual assessment of the feasibility and effectiveness30
#
Risk-mitigation
measures
Deﬁnition/explanation in
place in the EU (e.g.)
Score for feasibility of
measures in WILD
salamanders integrating
human resources,
stakeholder willingness
to comply/implement,
technical complexity,
feasibility of monitoring,
treatment costs and
long-term outlook, e.g.
permanent efforts
Score for
effectiveness in
protecting WILD
salamanders
against Bsal
infection
1 Site deﬁnition Deﬁning a site robustly to
identify opportunities for
disease spread between sites
2 Site visitation strategy Deﬁning a site visitation
strategy when attending
multiple sites in sequence
3 Cleaning and
disinfection of ﬁeld
worker body parts
Cleaning and washing or
wiping with a suitable
disinfectant (see Section 3.2.1)
of hands, arms, knees, etc.,
before a site is entered and/or
after ﬁnishing work at a site
4 Cleaning and
disinfection of ﬁeld
equipment
Cleaning and disinfection of
footwear and equipment (e.g.
vehicles, nets, balances) at
the commencement of
ﬁeldwork and between each
sampling site
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#
Risk-mitigation
measures
Deﬁnition/explanation in
place in the EU (e.g.)
Score for feasibility of
measures in WILD
salamanders integrating
human resources,
stakeholder willingness
to comply/implement,
technical complexity,
feasibility of monitoring,
treatment costs and
long-term outlook, e.g.
permanent efforts
Score for
effectiveness in
protecting WILD
salamanders
against Bsal
infection
5 Use disposable items Use of disposable items (e.g.
single-use latex, nitrile or vinyl
gloves) for moving and
handling salamanders
6 Care in handling
salamanders
If handling is essential, ensure
that individuals do not have
their exposure to pathogens
elevated over their
background exposure levels
7 Hands disinfection If gloves for handling animals
are unavailable, disinfect
hands with 70% ethanol and
wash hands thoroughly in
water after treatment. If
ethanol is not available, the
minimum treatment is hand
washing in the water to which
the amphibian is usually
exposed
8 Single use of
containers for
temporarily holding
salamanders
For temporarily held animals,
ensure single-use or
disinfected containers
between each animal. Adults
should not be held in groups
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#
Risk-mitigation
measures
Deﬁnition/explanation in
place in the EU (e.g.)
Score for feasibility of
measures in WILD
salamanders integrating
human resources,
stakeholder willingness
to comply/implement,
technical complexity,
feasibility of monitoring,
treatment costs and
long-term outlook, e.g.
permanent efforts
Score for
effectiveness in
protecting WILD
salamanders
against Bsal
infection
9 Integrated hygiene
approach
An integrated approach to
prevent or limit disease
transmission includes all the
single measures for hygiene
procedures and good practices
outlined above (from ex-3 to
ex-9, no ex-6)
10 Avoid wild
salamanders capture
and handling
Avoiding or minimising the
capture, handling and housing
of wild salamanders helps
reduce or remove
anthropogenic sources of
disease transmission between
animals and introduction/
spread from one place to
another
11 Prevent translocation
of wild animals
Treating translocated
amphibians as if they are
infected can help mitigate the
risk of intentional translocation
and therefore disease spread
12 Prevent return of
captive animals to the
wild
Wild amphibians and their
larvae that need to be housed
for some time in a captive
situation (e.g. laboratory, zoo
or captive breeding facilities)
should not be returned to the
wild. The measure includes
increasing awareness of
salamanders’ keepers that
should not release kept
salamanders into the wild
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#
Risk-mitigation
measures
Deﬁnition/explanation in
place in the EU (e.g.)
Score for feasibility of
measures in WILD
salamanders integrating
human resources,
stakeholder willingness
to comply/implement,
technical complexity,
feasibility of monitoring,
treatment costs and
long-term outlook, e.g.
permanent efforts
Score for
effectiveness in
protecting WILD
salamanders
against Bsal
infection
13 Increase public
awareness and
participation
Disease information and
education campaigns to
promote participation and
enforce hygiene protocols and
good practices via multiple
tools (e.g. installation of
signage for people visiting
natural areas and producing
informational ﬂyers). It
includes facilitating reporting
of signs/symptoms (e.g.
sighting for invasive species),
and means to communicate
observations of sick or dead
animals (e.g. via creation of
hotlines)
14 Collect and send dead
animals for Bsal
diagnosis
As a part of passive
surveillance, dead amphibians
should be collected and sent
for disease diagnosis
15 Set up wildlife disease
emergency teams for
passive surveillance
A contact for reporting and
consultation in the case a
dead salamander is found.
This measure includes a
laboratory where testing
salamanders for Bsal (see
Section 3.1.2.1), reporting the
Bsal-positive animals and
accompanying relevant
information to the local
authorities can be conducted
(see Section 3.1.2.2)
16 Wild population
monitoring
To collate and retrieve data on
population sizes, distributions
and trends
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#
Risk-mitigation
measures
Deﬁnition/explanation in
place in the EU (e.g.)
Score for feasibility of
measures in WILD
salamanders integrating
human resources,
stakeholder willingness
to comply/implement,
technical complexity,
feasibility of monitoring,
treatment costs and
long-term outlook, e.g.
permanent efforts
Score for
effectiveness in
protecting WILD
salamanders
against Bsal
infection
17 Active surveillance To actively collect data on Bsal
presence in amphibian
populations by visiting and
screening for disease local
populations of salamanders
according to a clearly deﬁned
and harmonised sampling
strategy (see Sections 3.1.2.1
and 3.1.2.2)
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